Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3042810	li-bam42	ng/l (ng/l)	1589	1620	0.49%
3042810	li-bam42	— (—)	739	755	100.00%	Distribution not available
3042810	li-beeta-amyloidi42proteiini,likvor	ng/l (ng/l)	5	5	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Any dementia

801

426

13.86

307.65

1.0

575.93

759.89

ng/l

11.67

578

244

Alzheimer’s disease, wide definition, excluding more controls

548

80.31

307.65

1.0

529.27

867.00

ng/l

6.26

400

Alzheimer’s disease (Late onset), excluding more controls

371

62.18

307.65

1.0

541.42

824.67

ng/l

4.02

259

N06DA Anticholinesterases

684

419

13.84

307.65

1.0

534.33

742.48

ng/l

14.09

485

242

Any dementia, excluding more controls

799

335

17.38

307.65

1.0

576.86

729.88

ng/l

7.61

576

198

Implicit Sepsis

838

1211

5.47

307.65

1.0

784.53

706.11

ng/l

4.04

658

758

Other symptoms and signs involving cognitive functions and awareness

1275

501

25.29

307.65

1.0

751.41

700.10

ng/l

1.51

1019

270

Alzheimer’s disease, wide definition

555

273

17.89

307.65

1.0

527.31

707.58

ng/l

9.54

405

153

Alzheimer disease

617

346

14.05

307.65

1.0

537.87

702.55

ng/l

8.58

440

189

Use of donepezil

410

292

14.18

307.65

1.0

518.56

687.41

ng/l

8.41

300

164

Normal-pressure hydrocephalus

330

47.23

307.65

1.1

1.0

545.53

605.04

ng/l

0.62

Psychiatric diseases

985

687

7.26

307.65

1.0

698.17

826.65

ng/l

7.61

673

466

Unspecific neurodegenerative disorder

857

415

14.90

307.65

1.0

556.12

776.35

ng/l

15.53

600

238

Use of anticholinesterases

684

419

13.84

307.65

1.0

534.33

742.48

ng/l

14.09

485

242

Other mental disorders due to brain damage and dysfunction and to physical disease

357

129

30.02

307.65

1.0

744.69

785.78

ng/l

0.41

239

Condition for Implicit Sepsis (Organ dysfunction codes)

1263

905

10.38

307.65

1.0

760.57

724.02

ng/l

1.13

984

516

Alzheimer disease, including avohilmo

707

390

13.67

307.65

1.0

549.82

727.67

ng/l

10.23

497

220

Any mental disorder

930

885

5.31

307.65

1.0

685.35

815.07

ng/l

8.90

650

579

Degenerative diseases of the nervous system

763

405

14.89

307.65

1.0

593.17

750.56

ng/l

7.93

554

232

Symptoms and signs involving cognition, perception, emotional state and behaviour

1401

822

12.21

307.65

1.0

751.65

740.78

ng/l

0.21

1078

459

Dementia, including avohilmo

965

458

15.22

307.65

1.0

594.69

800.53

ng/l

15.24

685

274

Other degenerative diseases of the nervous system

756

179

33.77

307.65

1.0

595.18

835.38

ng/l

9.58

551

134

Alzheimer’s disease (Late onset)

378

233

14.43

307.65

1.0

538.18

692.97

ng/l

5.96

264

127

Alzheimer disease, excluding more controls

599

68.33

307.65

1.0

535.50

845.20

ng/l

6.94

431

Dementia

907

371

17.68

307.65

1.0

578.71

775.44

ng/l

12.36

639

224

Hydrocephalus

355

129

31.12

307.65

1.1

1.0

548.70

674.29

ng/l

2.37

105

Organic, including symptomatic, mental disorders

1112

500

16.81

307.65

1.0

635.68

797.91

ng/l

11.09

773

318

Alzheimer’s disease (Early onset)

199

52.87

307.65

1.0

505.63

726.60

ng/l

1.69

150

Dementia in Alzheimer disease

269

136

17.48

295.53

1.0

533.52

700.42

ng/l

4.19

157

Use of other anti-dementia drugs

362

342

9.51

282.17

1.0

539.72

650.14

ng/l

4.00

243

187

Use of memantine

362

342

9.51

282.17

1.0

539.72

650.14

ng/l

4.00

243

187

Use of rivastigmine

253

225

11.72

243.12

1.0

538.15

655.50

ng/l

3.45

181

128

Other neurological diseases

650

1330

3.98

209.28

1.0

716.71

737.64

ng/l

0.40

332

993

Memory loss

172

107

16.86

204.18

1.0

705.45

794.47

ng/l

1.02

126

Depression or dysthymia

423

380

6.28

192.21

1.0

801.79

806.64

ng/l

0.05

288

247

Intracranial trauma

329

375

6.60

180.34

1.0

752.57

822.73

ng/l

1.32

203

282

Mood disorders, excluding more controls

570

855

4.09

172.64

1.0

805.43

818.40

ng/l

0.21

398

569

Neurological diseases

452

443

5.17

163.22

1.0

723.54

830.49

ng/l

3.36

310

326

Symptoms and signs involving the nervous and musculoskeletal systems

482

1281

3.81

155.99

1.0

755.45

722.64

ng/l

0.72

297

888

Unspecified dementia

140

15.80

152.00

1.0

609.75

717.29

ng/l

1.16

108

Circumscribed brain atrophy

37.72

145.99

1.0

824.93

682.83

ng/l

0.74

Dizziness and giddiness

390

747

4.27

138.97

1.0

726.30

716.30

ng/l

0.13

241

412

Concussion

251

365

5.99

134.06

1.0

770.80

827.15

ng/l

0.85

162

273

Other antidepressants

647

1150

2.95

116.31

1.0

749.63

733.06

ng/l

0.34

432

799

Recurrent or chronic depression

201

219

6.68

109.74

1.0

843.91

804.91

ng/l

0.42

127

153

Parkinson's disease, excluding more controls

101

14.08

108.50

1.0

616.76

865.73

ng/l

4.26

Undefined dementia

140

163

8.08

99.56

1.0

609.75

628.24

ng/l

0.16

108

Other and unspecified degenerative diseases of nervous system

26.82

98.96

1.1

1.0

729.37

665.27

ng/l

0.27

Parkinson's disease, strict definition, excluding more controls

14.16

98.42

1.1

1.0

621.85

862.24

ng/l

3.61

Other symptoms and signs involving the nervous and musculoskeletal systems

309

872

3.58

91.85

1.0

758.21

721.66

ng/l

0.63

196

608

Abnormalities of gait and mobility

150

236

6.54

91.19

1.1

1.0

675.36

676.13

ng/l

0.01

150

Medical observation and evaluation for suspected diseases and conditions

412

668

3.18

82.98

1.0

746.86

719.28

ng/l

0.46

239

503

Delirium, not induced by alcohol and other psychoactive substances

102

116

8.96

82.01

1.0

672.40

755.37

ng/l

0.80

Anxiety disorders, excluding more controls

364

773

3.14

78.72

1.0

839.25

822.67

ng/l

0.24

270

520

Implicit bacterial Sepsis

274

716

3.55

78.49

1.0

768.26

689.39

ng/l

2.05

206

438

Selective serotonin reuptake inhibitors

549

1150

2.52

74.88

1.0

773.15

733.06

ng/l

0.98

361

799

Alzheimer’s disease (Atypical or mixed)

9.25

72.40

1.0

1.1

589.94

689.29

ng/l

0.76

Mood [affective] disorders

573

1631

2.32

69.84

1.0

803.75

735.37

ng/l

2.62

401

1129

Mood disorders

572

1633

2.31

69.02

1.0

804.46

734.78

ng/l

2.70

400

1131

Schizophrenia or delusion, excluding more controls

150

314

4.77

65.93

1.0

793.72

829.92

ng/l

0.38

112

212

Bacterial Sepsis

277

792

3.14

65.10

1.0

765.13

685.66

ng/l

2.15

208

483

Depression

523

1561

2.32

64.31

1.0

815.29

736.07

ng/l

3.07

361

1091

Viral Sepsis

148

321

4.67

63.24

1.1

1.0

766.11

683.23

ng/l

1.22

105

194

Use of galantamine

114

7.86

62.61

1.1

1.0

561.24

599.80

ng/l

0.32

Implicit viral Sepsis

146

320

4.62

61.60

1.1

1.0

768.96

682.81

ng/l

1.28

104

193

Vascular dementia

9.44

59.41

1.0

626.19

723.89

ng/l

0.69

Extrapyramidal and movement disorders

259

878

2.98

57.27

1.0

735.15

711.62

ng/l

0.33

171

585

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

149

141

5.32

55.72

1.0

802.84

716.79

ng/l

0.78

103

Other and unspecified hydrocephalus

16.24

54.17

1.1

1.0

613.58

618.91

ng/l

0.02

Dementia in other diseases classified elsewhere

10.70

52.82

1.0

667.25

688.22

ng/l

0.10

Vascular dementia (subcortical)

17.73

49.91

1.1

1.0

577.33

717.09

ng/l

0.55

Nonorganic sleeping disorders, excluding more controls

143

6.06

49.39

1.0

853.02

830.32

ng/l

0.14

Frontotemporal dementia, wide, incl. Pick's disease

32.23

49.30

1.0

755.79

574.00

ng/l

—

General examination and investigation of persons without complaint and reported diagnosis

327

668

2.62

48.31

1.0

818.94

719.28

ng/l

2.48

209

503

Substance abuse, excluding more controls

228

681

2.94

48.18

1.0

814.18

811.69

ng/l

0.03

162

460

Malaise and fatigue

289

935

2.59

47.40

1.0

740.13

712.39

ng/l

0.44

197

635

Traumatic subdural haemorrhage

108

6.81

47.17

1.0

593.15

822.52

ng/l

3.53

Neurological diseases, wide definition

113

5.93

46.69

1.0

723.55

811.82

ng/l

0.69

Epilepsy

188

596

3.17

46.48

1.0

746.32

729.10

ng/l

0.18

136

415

Postprocedural disorders of nervous system

7.99

45.60

1.0

736.19

754.02

ng/l

0.08

Injuries to the head

535

1772

1.97

43.60

1.0

766.69

742.31

ng/l

0.56

354

1232

Frontotemporal dementia

31.23

42.69

1.0

838.15

552.80

ng/l

—

Benzodiazepine use

500

1814

1.97

41.31

1.0

786.35

736.51

ng/l

1.49

347

1241

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

225

4.38

39.05

1.0

800.62

827.23

ng/l

0.19

156

Psychotic depression

13.50

38.26

1.0

702.04

713.00

ng/l

0.04

Bipolar affective disorders

105

267

3.97

36.62

1.0

767.35

770.04

ng/l

0.02

196

Depression medications

135

174

3.92

36.51

1.0

821.49

709.49

ng/l

1.47

127

Intracranial injury

287

1232

2.26

36.24

1.0

738.39

720.66

ng/l

0.26

175

833

Unspecified mental disorder

214

843

2.55

35.60

1.0

760.80

758.47

ng/l

0.03

155

580

Kela-code for severe mental illness

198

760

2.62

34.78

1.0

760.57

755.55

ng/l

0.05

142

526

Personality disorders, excluding more controls

217

4.22

34.59

1.0

829.05

823.53

ng/l

0.04

152

Other extrapyramidal and movement disorders in other diseases

151

514

2.97

33.43

1.0

789.16

702.05

ng/l

1.21

100

349

Other special examinations and investigations of persons without complaint or reported diagnosis

300

668

2.28

33.10

1.0

788.52

719.28

ng/l

1.45

196

503

Convulsions, not elsewhere classified

134

422

3.16

33.04

1.0

711.95

745.92

ng/l

0.32

292

Fall on same level

533

1645

1.82

32.84

1.0

754.52

751.31

ng/l

0.05

360

1154

Persons encountering health services for examination and investigation

296

668

2.23

30.96

1.0

754.54

719.28

ng/l

0.55

198

503

Examination and observation for other reasons

252

666

2.31

30.20

1.0

741.45

719.28

ng/l

0.32

162

503

Focal epilepsy

129

434

3.00

29.18

1.0

744.40

737.93

ng/l

0.05

288

Use of levodopa decarboxylase inhibitor

105

321

3.32

28.03

1.0

639.92

667.81

ng/l

0.28

198

Other degenerative diseases of the basal ganglia

9.53

28.01

1.1

1.0

601.20

518.52

ng/l

0.48

General symptoms and signs

488

1374

1.78

27.81

1.0

745.93

741.04

ng/l

0.08

321

972

Anxiety (asthma-related co-morbidities)

235

839

2.22

27.34

1.0

855.98

735.57

ng/l

3.27

174

596

Episodal and paroxysmal disorders

473

1362

1.78

27.12

1.0

763.55

721.45

ng/l

1.08

316

937

Other anxiety disorders

179

651

2.45

26.80

1.0

826.22

735.97

ng/l

1.66

130

458

Focal epilepsy, mode (most common among epilepsy diagnosis)

116

387

3.03

26.69

1.0

743.92

741.82

ng/l

0.01

258

Communicating hydrocephalus

9.50

26.66

1.2

1.0

484.10

551.95

ng/l

—

Syncope and collapse

226

924

2.18

25.80

1.0

725.26

720.57

ng/l

0.05

137

631

Focal epilepsy, strict definition

118

408

2.92

25.50

1.0

750.59

735.42

ng/l

0.12

268

Other symptoms and signs involving general sensations and perceptions

9.84

25.05

1.0

724.64

511.40

ng/l

—

STROKE

334

1228

1.90

24.86

1.0

761.50

736.68

ng/l

0.41

225

863

Behavioural syndromes associated with physiological disturbances and physical factors

133

497

2.69

24.77

1.0

867.52

734.75

ng/l

2.19

347

Cerebrovascular diseases

387

1556

1.79

24.18

1.0

742.48

729.69

ng/l

0.19

252

1061

Parkinson's disease, including avohilmo

112

389

2.91

24.09

1.0

635.29

690.14

ng/l

0.67

249

Non-selective monoamine reuptake inhibitors

185

791

2.28

24.06

1.0

873.94

723.89

ng/l

3.18

123

560

Other disorders of urethra and urinary system

317

1278

1.87

22.90

1.0

736.27

727.66

ng/l

0.12

212

865

Sleep disorders

106

372

2.87

22.35

1.0

838.89

749.02

ng/l

1.02

260

Metabolic disorders

446

1646

1.69

22.18

1.0

768.41

748.16

ng/l

0.39

320

1118

Schizophrenia, schizotypal and delusional disorders

152

640

2.39

22.16

1.0

793.66

739.72

ng/l

0.75

113

446

Headache

270

1177

1.92

21.91

1.0

772.34

738.23

ng/l

0.55

179

842

Other and unspecified nonorganic psychotic disorders

298

3.07

21.70

1.0

841.18

785.20

ng/l

0.46

203

Schizophrenia or delusion

150

634

2.38

21.69

1.0

793.72

739.50

ng/l

0.75

112

443

Hypothyroidism (congenital or acquired)

172

3.18

20.54

1.0

856.20

709.49

ng/l

1.54

127

All anxiety disorders

235

968

1.96

20.07

1.0

855.98

736.69

ng/l

3.33

174

683

Hypothyroidism, levothyroxine purchases

172

3.15

20.05

1.0

849.73

709.49

ng/l

1.43

127

Hypothyroidism and >3 levothyroxin purchases

172

3.15

20.05

1.0

849.73

709.49

ng/l

1.43

127

Parkinson's disease

101

374

2.73

19.37

1.0

616.76

690.08

ng/l

1.04

237

Progressive vascular leukoencephalopathy

6.43

19.35

1.0

594.23

611.75

ng/l

0.09

Sleep disorders (combined)

434

1748

1.63

19.26

1.0

785.18

728.50

ng/l

1.69

301

1198

Disorders of lipoprotein metabolism and other lipidaemias

416

1588

1.65

19.21

1.0

751.10

745.74

ng/l

0.08

303

1075

Infections, IBD-co-morbidities

4.37

18.83

1.0

748.69

799.19

ng/l

0.30

Anxiety disorders

366

1582

1.64

17.07

1.0

841.42

738.56

ng/l

3.78

272

1088

Parkinson's disease, strict definition

342

2.69

17.02

1.1

1.0

621.85

682.74

ng/l

0.72

213

Manic episode

7.63

17.00

1.0

740.88

635.24

ng/l

0.34

Neurotic, stress-related and somatoform disorders

360

1565

1.64

16.64

1.0

845.86

738.58

ng/l

3.95

266

1075

Abnormal involuntary movements

263

2.92

16.59

1.0

849.92

722.50

ng/l

1.24

179

Pure hypercholesterolaemia

368

1518

1.63

16.50

1.0

709.32

736.83

ng/l

0.59

272

1016

Constipation

391

1755

1.60

16.41

1.0

747.97

736.74

ng/l

0.19

269

1205

Sequelae of injuries of head

100

4.27

16.25

1.0

793.04

754.51

ng/l

0.16

Spondylopathies

356

1318

1.64

16.18

1.0

782.03

724.47

ng/l

1.31

218

940

Nonorganic sleeping disorders

323

2.68

16.09

1.0

853.02

770.62

ng/l

0.78

225

Dorsalgia

393

1326

1.61

15.97

1.0

764.72

725.40

ng/l

0.85

245

944

Other intervertebral disc disorders

353

1324

1.64

15.76

1.0

776.01

724.48

ng/l

1.10

235

943

Other dorsopathies, not elsewhere classified

400

1326

1.59

15.62

1.0

759.81

725.40

ng/l

0.71

254

944

Open wound of head

215

1160

1.83

15.61

1.0

744.05

730.38

ng/l

0.17

145

791

Schizoaffective disorder

130

3.73

15.57

1.0

835.03

751.84

ng/l

0.60

Lower back pain or/and sciatica

422

1891

1.55

15.49

1.0

772.39

742.36

ng/l

0.58

254

1335

severe traumatic brain injury, does not include concussion

114

499

2.30

15.40

1.0

699.28

728.71

ng/l

0.25

325

Cerebrovascular diseases (FINNGEN)

182

668

1.96

15.27

1.0

743.12

735.08

ng/l

0.08

128

494

Other disorders of ear

413

1785

1.55

14.81

1.0

760.27

738.58

ng/l

0.40

272

1242

Focal brain injury

5.43

14.47

1.0

911.27

845.87

ng/l

0.13

Generalized anxiety disorder

161

3.31

14.44

1.0

804.27

792.96

ng/l

0.06

109

Insomnia

269

2.73

14.23

1.0

800.22

763.10

ng/l

0.29

187

Follow-up examination after treatment for conditions other than malignant neoplasms

158

517

2.01

14.01

1.0

764.54

689.73

ng/l

1.34

113

397

Falls/tendency to fall

430

1417

1.52

13.65

1.0

748.62

754.30

ng/l

0.09

295

996

Monoamine oxidase A inhibitors

200

2.97

13.44

1.1

1.0

804.87

727.44

ng/l

0.49

144

Factors influencing health status and contact with health services

139

330

2.12

13.27

1.0

757.46

696.87

ng/l

0.62

247

Viral infections of the central nervous system

117

3.63

13.13

1.0

836.12

707.74

ng/l

0.65

Statin medication

262

877

1.68

12.80

1.0

759.69

772.56

ng/l

0.17

182

629

Care involving use of rehabilitation procedures

283

1679

1.60

12.74

1.0

795.61

737.87

ng/l

1.38

233

1117

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

1176

0.38

12.73

1.0

649.02

718.66

ng/l

0.86

771

Dorsopathies

395

1327

1.52

12.63

1.0

780.21

725.40

ng/l

1.33

251

944

Speech disturbances, not elsewhere classified

177

3.03

12.44

1.0

637.69

659.59

ng/l

0.15

102

Other diseases of intestines

413

1613

1.49

12.34

1.0

799.05

740.41

ng/l

1.52

284

1111

Pain in throat and chest

342

1352

1.55

12.33

1.0

776.34

734.51

ng/l

0.87

239

915

Low back pain

276

1323

1.61

12.23

1.0

743.79

725.27

ng/l

0.26

172

943

Disorders of thyroid, IBD co-morbidities

3.53

12.21

1.0

632.80

822.24

ng/l

1.74

Viral encephalitis, not elsewhere classified/unspecified

6.15

12.18

1.0

694.17

590.75

ng/l

0.35

Sciatica+with lumbago

213

1190

1.70

12.16

1.0

818.79

728.19

ng/l

1.59

123

856

Parasetamol

299

958

1.60

11.80

1.0

731.18

747.48

ng/l

0.24

202

707

Shoulder lesions

346

1391

1.53

11.70

1.0

827.69

730.99

ng/l

2.95

232

956

Other encephalitis

5.60

11.68

1.0

618.75

586.57

ng/l

0.12

Symptoms and signs involving emotional state

9.43

11.67

1.0

671.50

407.80

ng/l

—

Alcohol abuse, main dg, excluding more controls

163

3.02

11.57

1.0

826.03

823.01

ng/l

0.01

106

Other reaction to severe stress, and adjustment disorders

123

625

1.97

11.42

1.0

894.37

737.76

ng/l

2.79

444

Conductive and sensorineural hearing loss

360

1671

1.50

11.33

1.0

765.10

729.35

ng/l

0.68

234

1150

Degeneration of the brain due to alcohol

5.65

11.22

1.0

712.40

624.28

ng/l

0.39

Somnolence, stupor and coma

5.58

11.18

1.0

659.86

540.69

ng/l

0.43

Sequelae of cerebrovascular disease

156

753

1.83

11.17

1.0

727.95

709.60

ng/l

0.19

111

487

Poisoning by medicine

362

2.28

10.99

1.0

845.92

776.29

ng/l

0.56

251

Poisoning by drugs, medicaments and biological substances

407

2.20

10.96

1.0

831.55

754.89

ng/l

0.72

284

Lumbar disc prolapse

260

1307

1.58

10.91

1.0

784.87

724.74

ng/l

1.18

168

937

Other headache syndromes

157

877

1.80

10.91

1.0

763.61

718.41

ng/l

0.60

611

249

1405

1.59

10.84

1.0

784.66

745.96

ng/l

0.67

174

968

Encephalitis

5.20

10.82

1.0

618.75

614.62

ng/l

0.01

Abnormal findings on diagnostic imaging of central nervous system

3.88

10.68

1.1

1.0

723.77

699.24

ng/l

0.09

236

1358

1.60

10.56

1.0

787.46

747.42

ng/l

0.67

167

933

Persistent mood disorders

351

2.26

10.46

1.0

814.68

733.42

ng/l

0.85

244

Persons encountering health services for specific procedures and health care

416

1799

1.43

10.44

1.0

781.14

742.73

ng/l

0.97

312

1210

Alcohol use disorder, Swedish definition

229

1328

1.61

10.41

1.0

784.94

750.74

ng/l

0.53

161

917

Transient ischemic attack

236

1226

1.60

10.40

1.0

794.10

702.67

ng/l

1.87

156

798

Symptoms and signs involving speech and voice

142

782

1.82

10.38

1.0

754.57

718.16

ng/l

0.48

109

518

Disorders of adult personality and behaviour

469

2.08

10.38

1.0

845.75

749.77

ng/l

1.26

339

Other diseases of urinary system

399

1557

1.44

10.20

1.0

724.68

736.68

ng/l

0.20

276

1065

Dysphagia

116

603

1.93

10.16

1.0

698.56

708.77

ng/l

0.09

387

Sensorineural hearing loss

340

1618

1.47

10.06

1.0

761.13

724.01

ng/l

0.68

219

1111

Mental and behavioural disorders due to psychoactive substance use

236

1415

1.58

10.02

1.0

808.14

744.60

ng/l

1.39

169

982

Cervicalgia

431

2.10

9.91

1.0

785.54

690.05

ng/l

0.91

307

Superficial injury of head

418

2.11

9.89

1.0

767.52

739.61

ng/l

0.22

282

Other sleep disorders

219

2.58

9.85

1.0

779.66

737.85

ng/l

0.23

149

Mental and behavioural disorders due to alcohol

209

1266

1.61

9.75

1.0

808.22

747.37

ng/l

1.12

147

881

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

1216

0.45

9.57

1.0

845.39

721.21

ng/l

1.30

798

Traumatic subarachnoid haemorrhage

6.21

9.47

1.1

1.0

770.00

756.44

ng/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

493

1.99

9.46

1.0

800.62

752.53

ng/l

0.44

351

Malignant neoplasm of digestive organs

1051

0.38

9.28

1.0

666.11

702.84

ng/l

0.30

680

Use of hypnotics and sedatives

425

1758

1.40

9.27

1.0

796.52

732.00

ng/l

2.05

299

1200

Substance abuse

228

1401

1.56

9.26

1.0

814.18

746.26

ng/l

1.47

162

975

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

725

0.26

9.14

1.0

773.64

708.54

ng/l

0.26

471

Anaemias

172

2.44

9.12

1.0

771.75

709.49

ng/l

0.43

127

Hyperplasia of prostate

185

635

1.67

9.01

1.0

671.63

769.20

ng/l

2.15

130

421

Other soft tissue disorders, not elsewhere classified

328

1398

1.45

8.86

1.0

799.15

730.22

ng/l

1.84

227

959

Nerve, nerve root and plexus disorders

414

1877

1.39

8.74

1.0

800.14

733.82

ng/l

1.98

300

1271

Mental and behavioural disorders due to alcohol, excluding acute intoxication

186

1161

1.61

8.64

1.0

814.84

750.28

ng/l

1.10

132

812

Cerebral cysts

3.75

8.62

1.0

740.85

668.26

ng/l

0.30

Spinal stenosis

225

1143

1.55

8.61

1.0

761.91

710.83

ng/l

0.83

137

808

Personality disorders

463

1.97

8.55

1.0

829.05

754.92

ng/l

0.85

329

Vascular dementia (mixed)

8.62

8.49

1.0

669.67

532.20

ng/l

—

Secondary parkinsonism+Parkinsonism in other disease

4.22

8.49

1.0

601.44

585.59

ng/l

—

Non-invasive ventilation

422

1.99

8.47

1.1

1.0

697.67

673.85

ng/l

0.24

294

Diseases of oesophagus, stomach and duodenum

412

1813

1.38

8.47

1.0

777.60

743.82

ng/l

0.70

297

1233

Persistent delusional disorders

154

2.75

8.44

1.0

696.97

723.98

ng/l

0.15

Stroke, including SAH

272

1362

1.48

8.43

1.0

746.28

716.43

ng/l

0.41

172

910

Hypertension, essential

321

1270

1.44

8.36

1.0

756.08

752.33

ng/l

0.05

235

887

Other functional intestinal disorders

178

1055

1.61

8.36

1.0

760.69

714.19

ng/l

0.62

123

699

Suicide or other Intentional self-harm

474

1.95

8.35

1.0

801.08

747.74

ng/l

0.47

337

Sleep apnoea

367

1789

1.39

8.10

1.0

783.20

733.43

ng/l

1.23

257

1230

Migraine without aura

224

2.37

7.96

1.0

932.00

751.30

ng/l

1.43

158

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

660

0.34

7.85

1.0

683.20

705.88

ng/l

0.10

420

Heart failure and coronary heart disease

695

0.40

7.76

1.0

863.59

686.11

ng/l

1.01

436

Sleep apnoea, including avohilmo

381

1800

1.38

7.75

1.0

801.74

730.20

ng/l

2.17

265

1238

Diseases of the ear and mastoid process

437

1634

1.36

7.72

1.0

776.69

739.49

ng/l

0.87

292

1139

Symptoms and signs involving the urinary system

309

1688

1.42

7.70

1.0

751.38

734.64

ng/l

0.26

216

1132

Disturbances of smell and taste

4.76

7.64

1.1

1.0

748.70

484.86

ng/l

—

Other external causes of accidental injury

309

1081

1.43

7.59

1.0

747.64

751.73

ng/l

0.05

213

731

Alcohol use disorder, ICD-based

169

1070

1.58

7.51

1.0

815.02

744.29

ng/l

1.16

120

738

Unspecified fall

177

1124

1.57

7.48

1.0

766.59

721.56

ng/l

0.57

121

749

Secondary parkinsonism

3.95

7.46

1.0

634.00

625.74

ng/l

—

Hypertensive diseases (excluding secondary)

200

754

1.54

7.30

1.0

759.86

750.04

ng/l

0.11

145

559

Restless leg syndrome

272

2.18

7.30

1.0

803.76

711.12

ng/l

0.73

171

Degeneration of nervous system due to alcohol

3.90

7.29

1.0

712.40

558.27

ng/l

0.94

Other lack of coordination

5.49

7.28

1.2

1.0

1200.40

580.13

ng/l

—

Pain in limb

275

1393

1.43

7.16

1.0

805.20

730.00

ng/l

1.79

189

957

Colorectal cancer, excluding all cancers (controls excluding all cancers)

837

0.40

7.15

1.0

622.12

708.17

ng/l

0.95

533

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

128

2.75

7.09

1.1

1.0

704.96

679.75

ng/l

0.12

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

560

0.33

7.07

1.0

612.59

705.05

ng/l

0.62

354

Mixed and other personality disorders

123

2.78

7.05

1.0

899.19

844.60

ng/l

0.22

Persons encountering health services in other circumstances, wide

454

1781

1.32

6.98

1.0

806.14

728.50

ng/l

2.95

336

1189

Bleeding

336

1782

1.37

6.96

1.0

705.37

746.58

ng/l

0.91

210

1232

Stroke, excluding SAH

250

1288

1.45

6.94

1.0

750.52

711.50

ng/l

0.56

161

856

Injuries to the thorax

169

1093

1.55

6.88

1.0

798.38

728.59

ng/l

1.18

109

743

Covid-19 confirmed case

103

588

1.76

6.84

1.1

1.0

689.95

737.98

ng/l

0.57

386

Hypertensive diseases

313

1273

1.39

6.78

1.0

746.87

752.64

ng/l

0.08

228

889

Hypertension

313

1273

1.39

6.77

1.0

746.87

752.64

ng/l

0.08

228

889

Cardiodefibrillation

1101

0.49

6.70

1.0

675.68

717.86

ng/l

0.28

725

Diseases of male genital organs

207

694

1.51

6.68

1.0

714.65

780.52

ng/l

1.13

150

465

Inflammatory diseases of the central nervous system

168

2.46

6.67

1.1

1.0

641.44

728.94

ng/l

0.65

108

Type 2 diabetes, wide definition

339

1623

1.36

6.62

1.0

732.88

740.17

ng/l

0.11

228

1119

Spondylosis

217

1274

1.46

6.61

1.0

799.77

721.03

ng/l

1.52

128

908

Any gastric operation

285

1016

1.41

6.46

1.0

767.85

735.51

ng/l

0.50

182

764

GASTRO-related operations

285

1016

1.41

6.46

1.0

767.85

735.51

ng/l

0.50

182

764

Provisional assignment of new diseases of uncertain etiology

143

904

1.59

6.46

1.0

721.46

744.73

ng/l

0.28

106

608

Rotator cuff syndrome

261

1375

1.41

6.44

1.0

821.91

728.48

ng/l

2.28

175

943

Codes for special purposes

143

905

1.58

6.43

1.0

721.46

744.09

ng/l

0.27

106

609

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

260

2.12

6.42

1.0

772.58

810.05

ng/l

0.20

179

Endocrine, nutritional and metabolic diseases

278

1003

1.41

6.39

1.0

757.45

726.14

ng/l

0.53

199

707

Accidents

300

1081

1.39

6.34

1.0

752.72

751.73

ng/l

0.01

209

731

Phobic anxiety disorders

125

2.65

6.29

1.0

971.71

779.02

ng/l

1.22

Hypotension

345

1.95

6.22

1.0

712.22

661.40

ng/l

0.40

210

Pain (limb, back, neck, head abdominally)

280

1002

1.40

6.18

1.0

766.74

713.09

ng/l

1.10

185

696

Heart failure, strict

117

1352

0.62

6.10

1.0

746.84

702.91

ng/l

0.52

875

Dental operations

267

974

1.41

6.10

1.0

734.55

726.12

ng/l

0.10

173

650

Cervical disc disorders

150

974

1.54

6.07

1.0

802.73

719.72

ng/l

1.24

104

701

Heart failure,strict

109

1280

0.61

6.04

1.0

756.67

704.67

ng/l

0.62

849

Soft tissue disorders

360

1399

1.34

6.02

1.0

771.71

730.22

ng/l

0.91

243

959

Fever of other and unknown origin

179

1119

1.49

5.99

1.0

782.50

732.83

ng/l

0.64

117

778

Specific personality disorders

385

1.88

5.98

1.0

815.40

756.28

ng/l

0.55

274

249

2.10

5.91

1.0

799.91

743.64

ng/l

0.49

162

Transient global amnesia

142

2.48

5.85

1.0

844.62

830.02

ng/l

0.07

Migraine

134

724

1.58

5.84

1.0

883.21

716.45

ng/l

3.10

512

Fracture of skull and facial bones

432

1.81

5.81

1.0

837.18

731.35

ng/l

0.91

300

External causes of morbidity and mortality

244

864

1.42

5.75

1.0

729.09

741.72

ng/l

0.16

170

580

All-cause Heart Failure

117

1330

0.63

5.68

1.0

742.24

703.47

ng/l

0.44

856

COPD, hospital admissions 1, only main diagnosis

854

0.51

5.67

1.0

789.03

705.04

ng/l

0.95

555

Diabetes medication

376

1746

1.31

5.64

1.0

764.85

741.63

ng/l

0.45

259

1208

COPD, hospital admissions

1183

0.58

5.58

1.0

813.58

701.28

ng/l

1.65

770

Lung cancer and mesothelioma

508

0.37

5.58

1.0

612.59

671.11

ng/l

0.34

329

Fracture of rib(s), sternum and thoracic spine

117

733

1.60

5.57

1.0

782.97

735.05

ng/l

0.55

490

Other CVD (FINNGEN)

241

1.97

5.53

1.0

718.30

699.73

ng/l

0.11

161

Other and unspecified polyneuropathies, also in other diseases

491

1.74

5.53

1.0

820.16

708.53

ng/l

1.33

321

Hypersomnia

4.89

5.52

1.1

1.0

913.40

593.20

ng/l

—

Parodontitis and operation codes

333

1962

1.32

5.51

1.0

754.60

745.81

ng/l

0.13

237

1345

Alcohol dependence

111

689

1.62

5.50

1.0

797.01

730.28

ng/l

0.79

473

Dental operations, only avohilmo

277

1035

1.37

5.49

1.0

738.63

732.70

ng/l

0.07

183

692

Sequelae of injuries, of poisoning and of other consequences of external causes

537

1.70

5.48

1.0

753.98

739.06

ng/l

0.12

366

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

571

0.37

5.45

1.0

669.88

708.82

ng/l

0.22

358

COPD, early/later onset

1193

0.59

5.44

1.0

801.61

700.23

ng/l

1.44

779

Dental caries 3, only avohilmo

323

1238

1.34

5.39

1.0

770.78

710.08

ng/l

1.47

223

826

Dental pulpitis 2, only avohilmo

286

1077

1.36

5.38

1.0

732.31

702.08

ng/l

0.52

196

714

COPD, hospital admissions 3, with asthma pneumonia sepsis

629

0.44

5.36

1.1

1.0

812.05

709.38

ng/l

0.79

399

Dental caries, including avohilmo

307

1169

1.34

5.34

1.0

762.87

707.24

ng/l

1.25

212

778

Parodontitis or operation codes

347

1956

1.31

5.33

1.0

753.88

745.16

ng/l

0.13

244

1341

Dental caries 1

307

1170

1.34

5.31

1.0

762.87

706.83

ng/l

1.26

212

779

COPD related to multimorbidity

988

0.56

5.28

1.1

1.0

834.96

700.49

ng/l

1.77

638

Dental caries 1, only avohilmo

311

1190

1.34

5.26

1.0

766.91

708.91

ng/l

1.35

214

794

Ischaemic Stroke, excluding all haemorrhages

225

1223

1.39

5.24

1.0

761.76

709.19

ng/l

0.77

146

796

Parodontitis

346

1957

1.30

5.23

1.0

753.88

745.16

ng/l

0.13

244

1341

Hypothyroidism, strict autoimmune, 3 medication purchases required

297

1519

1.34

5.22

1.0

779.12

729.84

ng/l

0.99

182

1059

Injuries to the shoulder and upper arm

304

1930

1.32

5.15

1.0

757.46

743.65

ng/l

0.19

206

1318

Influenza and pneumonia

369

1879

1.29

5.12

1.0

747.57

750.31

ng/l

0.04

250

1306

Later onset COPD

613

0.47

5.10

1.1

1.0

752.41

680.95

ng/l

0.52

367

Acute and transient psychotic disorders

217

2.08

5.08

1.0

809.49

775.43

ng/l

0.16

144

Colorectal cancer

636

0.42

5.05

1.0

672.22

705.98

ng/l

0.21

411

Cervicocranial syndrome

218

2.07

5.02

1.0

789.55

703.70

ng/l

0.50

156

Chronic periodontitis, including avohilmo

343

1959

1.30

4.99

1.0

752.47

745.62

ng/l

0.10

241

1343

Migraine without aura and triptan purchases

179

2.18

4.98

1.0

921.11

754.49

ng/l

1.09

126

Status epilepticus

3.14

4.92

1.0

906.15

647.50

ng/l

1.37

Diseases of the musculoskeletal system and connective tissue

172

590

1.46

4.91

1.0

787.94

698.25

ng/l

1.51

111

418

Other chronic obstructive pulmonary disease

1140

0.61

4.86

1.0

801.61

696.13

ng/l

1.53

740

Genitourinary diseases

218

783

1.40

4.85

1.0

701.26

773.55

ng/l

1.49

150

532

COPD, hospital admission 2, with asthma infections

765

0.52

4.83

1.1

1.0

794.63

707.87

ng/l

0.77

495

Disorders of lens

300

1439

1.32

4.78

1.0

764.40

738.71

ng/l

0.42

206

1008

Other problems related to primary support group, including family circumstances

116

2.44

4.76

1.0

774.65

775.89

ng/l

0.00

Symptoms and signs concerning food and fluid intake

176

2.17

4.75

1.1

1.0

680.92

675.50

ng/l

0.02

115

Cystitis

286

1321

1.33

4.73

1.0

749.13

724.21

ng/l

0.38

200

893

All influenza

560

1.63

4.73

1.0

745.61

731.97

ng/l

0.09

382

Dental pulpitis 2

276

1058

1.34

4.71

1.0

729.25

702.12

ng/l

0.45

186

697

Oter anti-inflammatory and antirheumatic agents, non-steroids

311

1.66

4.71

1.0

787.03

696.73

ng/l

1.10

211

Diabetes mellitus

367

1712

1.28

4.70

1.0

756.03

741.76

ng/l

0.25

250

1183

Dental caries 3

312

1217

1.31

4.66

1.0

769.12

708.61

ng/l

1.46

216

810

Colorectal adenocarcinoma

529

0.40

4.65

1.0

669.88

707.06

ng/l

0.21

339

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

355

1.79

4.65

1.0

702.40

766.10

ng/l

0.54

250

Migraine with aura

338

1.81

4.62

1.0

777.07

724.97

ng/l

0.39

234

Exposure to unspecified factor

329

1984

1.29

4.61

1.0

746.39

747.68

ng/l

0.02

252

1336

Abnormalities of breathing

298

1352

1.31

4.57

1.0

793.67

734.51

ng/l

1.32

210

915

Anomalies of pupillary function

4.45

4.57

1.0

854.00

607.40

ng/l

—

Symptoms and signs involving the digestive system and abdomen

370

1452

1.28

4.54

1.0

757.86

736.76

ng/l

0.37

256

986

Cardiovascular diseases (excluding rheumatic etc)

185

758

1.41

4.51

1.0

774.48

751.38

ng/l

0.26

124

561

Diabetes, varying definitions

365

1714

1.27

4.50

1.0

757.64

741.43

ng/l

0.29

249

1184

Hypothyroidism, strict autoimmune

266

1330

1.33

4.50

1.0

776.36

714.11

ng/l

1.28

162

926

Dystonia

105

2.49

4.46

1.1

1.0

908.57

690.00

ng/l

1.24

Dental caries 3 and operation codes

336

1338

1.29

4.46

1.0

764.29

722.75

ng/l

0.88

234

893

COPD

1176

0.64

4.45

1.0

801.10

699.92

ng/l

1.59

768

Visual disturbances and blindness

172

1227

1.40

4.44

1.0

814.39

723.24

ng/l

1.34

114

819

Symptoms and signs involving the circulatory and respiratory systems

346

1352

1.28

4.42

1.0

749.39

734.51

ng/l

0.24

242

915

Oxycodone

1049

0.59

4.40

1.0

761.80

672.65

ng/l

1.11

688

Other bacterial diseases

346

1880

1.27

4.39

1.0

741.04

746.06

ng/l

0.07

238

1292

Transport accidents

144

882

1.45

4.37

1.0

745.54

750.41

ng/l

0.05

595

Continuous positive airway pressure

379

1.69

4.35

1.0

803.40

675.84

ng/l

1.69

264

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

552

0.43

4.30

1.0

587.53

704.91

ng/l

1.13

347

Hard cardiovascular diseases

332

1671

1.28

4.25

1.0

738.89

739.81

ng/l

0.01

216

1160

Hypothyreosis and Thyroxine purchase for inclusion criteria

319

1646

1.28

4.21

1.0

770.96

731.86

ng/l

0.75

196

1146

Cervicobrachial syndrome

500

1.62

4.21

1.0

822.04

705.13

ng/l

0.94

367

Dental caries 1 and operation codes

325

1300

1.28

4.19

1.0

751.90

722.49

ng/l

0.54

223

868

Diseases of the myoneural junction and muscle

284

1.84

4.18

1.0

646.97

709.82

ng/l

0.41

186

Emotionally unstable personality disorder

135

2.23

4.07

1.0

874.47

852.28

ng/l

0.09

Retention of urine

133

777

1.45

4.05

1.0

653.94

713.13

ng/l

0.88

497

Other chronic obstructive pulmonary disease, including avohilmo

116

1408

0.68

4.04

1.0

765.36

707.08

ng/l

0.87

924

Fracture at wrist and hand level

109

728

1.50

4.01

1.0

768.46

750.07

ng/l

0.15

491

Disorders of ocular muscles, binocular movement, accommodation and refraction

141

983

1.42

4.00

1.0

762.39

749.52

ng/l

0.11

680

Hypothyroidism, other/unspecified

308

1596

1.28

3.96

1.0

776.78

732.25

ng/l

0.88

192

1113

Polyneuropathies and other disorders of the peripheral nervous system

564

1.57

3.94

1.0

820.16

715.48

ng/l

1.22

370

Gastro-oesophageal reflux disease

253

1730

1.30

3.88

1.0

792.09

737.96

ng/l

0.97

173

1176

Postmenopausal osteoporosis with pathological fracture

119

2.29

3.88

1.0

781.15

675.51

ng/l

0.34

All pneumoniae

346

1910

1.25

3.84

1.0

750.05

747.82

ng/l

0.03

234

1324

Other (not insulin) diabetes medications

360

1740

1.25

3.84

1.0

748.59

742.09

ng/l

0.10

247

1205

Other CVD

420

1.65

3.82

1.0

707.62

679.93

ng/l

0.20

265

Schizophrenia

322

1.74

3.82

1.0

737.41

756.66

ng/l

0.13

227

Diseases of the eye and adnexa

273

1056

1.30

3.81

1.0

741.14

760.93

ng/l

0.29

193

769

Biguanides

359

1776

1.25

3.80

1.0

753.80

746.95

ng/l

0.11

245

1232

Cramp and spasm

2.55

3.80

1.1

1.0

937.07

645.12

ng/l

1.68

Glucagon-like peptide-1 (GLP-1) analogues

223

1398

1.31

3.75

1.0

724.36

718.97

ng/l

0.07

146

935

Type 2 diabetes

358

1708

1.25

3.74

1.0

751.95

741.37

ng/l

0.17

245

1181

Cardiovascular diseases

158

615

1.40

3.74

1.0

806.84

746.47

ng/l

0.83

112

461

Injuries to the abdomen, lower back, lumbar spine and pelvis

125

866

1.44

3.73

1.0

757.92

719.74

ng/l

0.38

573

Visual disturbances

158

1149

1.38

3.72

1.0

795.05

729.19

ng/l

0.83

105

769

Senile cataract

277

1342

1.28

3.71

1.0

738.90

726.57

ng/l

0.17

184

936

Diplopia

296

1.76

3.69

1.0

707.78

732.46

ng/l

0.13

195

Hypoglycaemia, other or unspecified

116

2.25

3.64

1.1

1.0

747.15

660.42

ng/l

0.51

Pain in joint

197

978

1.34

3.60

1.0

851.87

714.00

ng/l

3.55

147

688

Other and unspecified myopathies

191

1.95

3.57

1.0

558.27

657.04

ng/l

0.54

116

Injury, poisoning and certain other consequences of external causes

185

684

1.36

3.57

1.0

724.58

736.12

ng/l

0.12

124

472

Injuries to the elbow and forearm

225

1570

1.30

3.50

1.0

716.46

743.45

ng/l

0.38

153

1073

Other/unspecified dorsalgia

119

831

1.43

3.47

1.0

832.27

717.58

ng/l

1.68

593

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

346

1709

1.24

3.46

1.0

768.59

741.66

ng/l

0.53

243

1181

Hernia

332

1817

1.24

3.46

1.0

761.26

746.27

ng/l

0.23

223

1256

Any event in cancer register

231

1760

0.78

3.44

1.0

748.04

756.68

ng/l

0.10

166

1209

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1146

0.68

3.44

1.0

776.22

744.77

ng/l

0.25

796

Diabetes, insulin treatment (Kela reimbursement)

365

1818

1.23

3.43

1.0

764.24

743.85

ng/l

0.38

255

1248

Disorders of the thyroid gland

323

1701

1.24

3.39

1.0

781.72

732.06

ng/l

1.06

204

1188

Later onset COPD, excluding more controls

504

0.54

3.35

1.1

1.0

773.28

660.78

ng/l

0.89

312

Fibromyalgia

127

2.13

3.35

1.0

1011.45

734.80

ng/l

2.23

Other and unspecified injuries of head

2.33

3.33

1.0

672.36

637.50

ng/l

0.16

Volume depletion

175

1.95

3.33

1.1

1.0

601.80

700.61

ng/l

0.62

103

Used for control exclusion in common control thyroid runs

363

1500

1.23

3.29

1.0

807.46

722.26

ng/l

2.68

241

1053

Certain infectious and parasitic diseases

353

1437

1.23

3.28

1.1

1.0

766.64

734.83

ng/l

0.62

247

982

Abdominal and pelvic pain

355

1452

1.23

3.27

1.0

762.20

736.76

ng/l

0.46

250

986

Other diseases of pleura

1145

0.68

3.27

1.0

736.72

708.69

ng/l

0.22

745

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

2.42

3.26

1.0

787.09

792.80

ng/l

0.02

Injury of muscle and tendon at shoulder and upper arm level

142

1040

1.37

3.26

1.0

764.91

729.72

ng/l

0.38

100

717

Other specified/unspecified disorders of bone/cartilage

2.80

3.26

1.0

910.60

670.45

ng/l

—

Eating disorders

2.34

3.23

1.0

990.14

736.45

ng/l

1.51

Migraine with aura and triptan purchases

170

1.95

3.23

1.0

807.68

751.56

ng/l

0.30

119

Fissure and fistula of anal and rectal regions

609

1.48

3.21

1.0

723.12

722.44

ng/l

0.00

421

Diverticular disease of intestine

282

1498

1.25

3.20

1.0

785.38

728.25

ng/l

1.06

189

1030

Pneumonias (Asthma/COPD co-morbidities)

339

1918

1.23

3.19

1.0

740.18

748.90

ng/l

0.13

229

1329

Malignant neoplasm

235

1768

0.79

3.19

1.0

747.35

753.70

ng/l

0.07

167

1216

Somatoform disorder

295

1.70

3.18

1.0

832.94

726.16

ng/l

0.75

199

Pedestrian injured in transport accident

130

2.09

3.18

1.0

682.00

674.64

ng/l

0.02

Meningitis

2.32

3.17

1.1

1.0

697.38

739.85

ng/l

0.16

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

334

1916

1.23

3.17

1.0

732.83

751.70

ng/l

0.32

225

1327

Malignant neoplasm of colon

364

0.41

3.17

1.0

682.13

681.25

ng/l

—

228

Special screening examination for infectious and parasitic diseases

201

1.75

3.16

1.0

859.38

737.90

ng/l

1.14

162

Disorders of vestibular function (Vertigo)

168

1260

1.33

3.16

1.0

734.29

728.01

ng/l

0.06

111

841

Voice disturbances

620

1.47

3.14

1.0

803.81

712.93

ng/l

1.33

412

Fracture of neck

124

2.11

3.14

1.1

1.0

705.56

651.78

ng/l

0.23

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

312

1584

1.24

3.13

1.0

747.27

735.85

ng/l

0.16

211

1093

312

1584

1.24

3.13

1.0

747.27

735.85

ng/l

0.16

211

1093

Fracture of forearm

182

1302

1.31

3.13

1.0

693.59

740.48

ng/l

0.69

124

890

Mental disorders, not otherwise specified

111

2.17

3.12

1.0

773.00

779.97

ng/l

0.02

Fracture of lumbar spine and pelvis

476

1.54

3.09

1.0

786.43

692.96

ng/l

0.89

299

Persons encountering health services for other counselling and medical advice, not elsewhere classified

378

1781

1.21

3.09

1.0

814.19

728.50

ng/l

2.85

277

1189

Nontraumatic intracranial haemmorrhage

453

1.55

3.09

1.0

622.23

710.01

ng/l

0.79

291

Explicit Sepsis

110

747

1.41

3.08

1.0

714.25

691.29

ng/l

0.21

457

Disorders of eyelid, lacrimal system and orbit

294

1869

1.23

3.05

1.0

729.21

735.98

ng/l

0.09

189

1280

Diarrhoea and gastroenteritis of presumed infectious origin

209

1483

1.28

3.04

1.0

793.58

745.96

ng/l

0.75

146

992

Fall on same level involving ice and snow

190

1471

1.29

3.01

1.0

719.72

733.50

ng/l

0.15

119

1004

Other disorders of fluid, electrolyte and acid-base balance

106

724

1.41

2.99

1.0

760.41

715.35

ng/l

0.48

463

Exclusions for E4_PCOS_CONSORTIUM

211

1031

1.28

2.96

1.0

791.82

737.93

ng/l

1.06

157

712

Vascular syndromes of brain in cerebrovascular disorders

2.55

2.96

1.1

1.0

816.11

730.75

ng/l

—

COPD (mode)

806

0.66

2.94

1.0

826.24

698.46

ng/l

1.71

525

Disorders of choroid and retina

297

1761

1.23

2.94

1.0

734.87

734.07

ng/l

0.01

209

1188

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

233

1728

0.80

2.92

1.0

756.54

756.59

ng/l

0.00

171

1187

Malignant neoplasm, wide definition for exclusion

233

1728

0.80

2.92

1.0

756.54

756.59

ng/l

0.00

171

1187

Type 2 diabetes, definitions combined

346

1705

1.21

2.90

1.0

748.07

741.39

ng/l

0.10

232

1179

Mixed conductive and sensorineural hearing loss

296

1.66

2.89

1.0

707.24

695.71

ng/l

0.07

195

Unstable angina pectoris

985

0.69

2.88

1.0

685.62

702.69

ng/l

0.13

652

Pain, not elsewhere classified

519

1.49

2.84

1.0

798.49

730.25

ng/l

0.59

363

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

234

1728

0.80

2.83

1.0

756.54

756.59

ng/l

0.00

171

1187

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

130

1204

0.74

2.82

1.1

1.0

706.34

714.80

ng/l

0.07

786

Diseases of inner ear

193

1479

1.28

2.82

1.0

721.30

729.61

ng/l

0.09

128

999

Amyloidosis, other/unspecified

3.10

2.82

1.1

1.0

642.36

590.70

ng/l

0.11

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

132

1216

0.75

2.82

1.1

1.0

705.98

716.46

ng/l

0.09

798

Malignant neoplasm of liver and intrahepatic bile ducts

0.00

2.79

0.0

1.0

—

576.03

—

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

0.00

2.78

0.0

1.0

—

619.62

—

Early lumbar disc prolapse, operated

2.17

2.76

1.0

943.87

797.54

ng/l

0.66

Finngen Rheumatological endpoints

331

1559

1.21

2.76

1.0

775.04

732.95

ng/l

0.92

235

1075

Other disorders of eye and adnexa

262

1.68

2.75

1.0

796.53

738.34

ng/l

0.34

169

Type 2 diabetes, strict (exclude DM1)

345

1711

1.20

2.74

1.0

748.07

742.58

ng/l

0.08

232

1184

Peripheral arterial reconstruction

409

0.49

2.74

1.1

1.0

600.83

678.09

ng/l

0.49

255

Bacterial infection, other or unspecified

182

1282

1.28

2.70

1.0

718.11

711.74

ng/l

0.07

128

847

3.00

2.70

1.0

683.67

708.21

ng/l

—

Pain in thoracic spine

279

1.65

2.69

1.0

891.74

711.10

ng/l

1.53

204

Other fall from one level to another

469

1.50

2.68

1.0

791.54

747.31

ng/l

0.31

318

Colonic or urogenital fistula

659

1.41

2.67

1.0

719.90

734.74

ng/l

0.11

448

Gastrointestinal diseases

199

780

1.28

2.66

1.0

774.31

720.71

ng/l

0.82

136

529

Endovascular or surgical operations to intracerebral aneurysms

154

1.89

2.66

1.1

1.0

548.54

747.92

ng/l

1.60

Disorders of parathyroid gland

472

1.49

2.66

1.0

844.84

691.22

ng/l

1.79

304

Disorders of synovium and tendon

174

1220

1.29

2.65

1.0

685.75

732.42

ng/l

0.95

130

845

Other cataract

169

1014

1.29

2.63

1.0

761.19

718.71

ng/l

0.51

118

686

Atherosclerosis, excluding cerebral and coronary sclerosis

998

0.71

2.63

1.0

698.47

692.90

ng/l

0.04

639

Disorders of other endocrine glands

126

927

1.34

2.60

1.0

854.33

713.47

ng/l

2.93

619

Other disorders of nervous system

127

1.98

2.60

1.0

845.53

716.49

ng/l

0.70

Gingivitis and periodontal diseases

322

1378

1.21

2.58

1.0

731.20

734.33

ng/l

0.04

215

937

Pneumonia, organism unspecified

304

1823

1.21

2.57

1.0

722.39

747.38

ng/l

0.44

203

1265

Exclusions for E4_PCOS_BROAD

322

1.59

2.55

1.0

820.78

748.67

ng/l

0.61

215

Oedema, not elsewhere classified

678

1.40

2.55

1.0

811.68

718.69

ng/l

1.23

469

In situ neoplasms

935

0.68

2.55

1.0

673.14

705.73

ng/l

0.29

593

Type 2 diabetes, definitions combined, including avohilmo

341

1689

1.20

2.54

1.0

736.40

741.22

ng/l

0.07

230

1168

Hypothyroidism, drug reimbursement

146

1.77

2.54

1.0

881.67

720.58

ng/l

1.04

107

Irritable bowel syndrome

591

1.42

2.53

1.1

1.0

799.66

716.03

ng/l

0.99

402

Presbyopia

136

1.92

2.50

1.0

862.21

766.68

ng/l

0.39

Inguinal hernia

205

1102

1.26

2.50

1.0

729.98

751.82

ng/l

0.26

133

750

Psoriasis

723

0.63

2.49

1.0

830.90

730.48

ng/l

0.60

502

Impingement syndrome of shoulder

720

1.38

2.47

1.0

776.56

721.84

ng/l

0.53

498

Hyperparathyroidism

416

1.50

2.47

1.0

853.41

683.92

ng/l

2.06

265

Bacterial meningitis

2.40

2.46

1.1

1.0

666.90

644.20

ng/l

—

Tramadol

288

1532

1.21

2.46

1.0

802.22

711.77

ng/l

2.72

205

1046

Propionic acid derivatives

314

1.43

2.43

1.0

688.65

704.64

ng/l

0.10

213

Carcinoma in situ of skin

204

0.39

2.41

1.1

1.0

686.00

651.72

ng/l

—

120

Assault by bodily force

2.12

2.38

1.1

1.0

692.31

828.35

ng/l

0.83

Osteoporosis

578

1.41

2.38

1.0

660.80

683.51

ng/l

0.15

375

Pleural effusion

401

0.52

2.38

1.0

575.62

685.46

ng/l

0.71

254

Other gastritis (incl. Duodenitis)

582

1.41

2.38

1.0

694.08

726.26

ng/l

0.26

380

Abnormal blood-pressure reading, without diagnosis

2.07

2.37

1.1

1.0

731.08

702.93

ng/l

0.06

Substance use, excluding alcohol

353

1.53

2.36

1.1

1.0

854.02

749.52

ng/l

1.12

252

Other disorders of penis

198

1.72

2.35

1.1

1.0

703.88

775.35

ng/l

0.60

128

Benign paroxysmal vertigo

710

1.37

2.35

1.1

1.0

725.55

701.81

ng/l

0.21

476

Cardiomyopathy

525

0.59

2.32

1.0

722.38

731.57

ng/l

0.04

346

Weight loss

199

1.72

2.31

1.1

1.0

707.35

677.06

ng/l

0.11

124

Benign neoplasm of brain and other parts of central nervous system

133

1.89

2.31

1.1

1.0

563.13

676.85

ng/l

1.01

Aortic aneurysm

625

0.63

2.31

1.0

760.07

701.52

ng/l

0.44

400

Injuries to the wrist and hand

318

1941

1.19

2.31

1.0

762.02

745.95

ng/l

0.26

243

1317

Abnormal findings in secretions and smears from cervix uteri vagina vulva

756

0.70

2.30

1.0

790.31

755.34

ng/l

0.25

544

Early lumbar disc prolapse operation

119

1.94

2.30

1.0

870.59

886.62

ng/l

0.05

Other disorders of glucose regulation and pancreatic internal secretion

155

1.81

2.29

1.1

1.0

781.59

694.82

ng/l

0.55

Valvular operations

434

0.55

2.28

1.0

763.06

713.26

ng/l

0.21

281

Acute alcohol intoxication

595

1.40

2.28

1.0

815.36

740.50

ng/l

0.85

405

Insulin, intermediate and long-acting

182

1431

1.25

2.26

1.0

789.54

722.44

ng/l

1.16

127

961

Other disorders of lacrimal gland

112

846

1.33

2.23

1.0

727.90

713.51

ng/l

0.12

571

Intracerebral haemorrhage

263

1.60

2.22

1.0

607.25

677.76

ng/l

0.44

157

Hypo-osmolality and hyponatraemia

406

1.48

2.22

1.0

786.65

717.19

ng/l

0.54

262

Strabismus

522

1.42

2.22

1.0

785.10

745.63

ng/l

0.22

360

Diseases of oral cavity, salivary glands and jaws

319

1378

1.19

2.21

1.0

758.10

734.33

ng/l

0.39

215

937

Heart failure and antihypertensive medication

538

0.67

2.21

1.0

818.33

734.07

ng/l

0.78

389

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

720

0.73

2.21

1.0

704.89

730.23

ng/l

0.25

478

Redundant prepuce, phimosis and paraphimosis

390

1.48

2.20

1.0

847.28

792.35

ng/l

0.33

261

Subjective visual disturbances

541

1.41

2.19

1.0

766.59

718.82

ng/l

0.35

369

Neuromuscular dysfunction of bladder

189

1.70

2.13

1.1

1.0

557.77

696.06

ng/l

1.49

124

Coronary artery bypass grafting

667

0.69

2.13

1.0

727.52

703.27

ng/l

0.13

435

Rheumatism, unspecified

330

1.52

2.13

1.0

947.76

679.90

ng/l

2.96

222

Osteoporosis with pathological fracture (FG)

152

1.78

2.12

1.0

781.15

678.69

ng/l

0.33

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

478

0.59

2.12

1.1

1.0

738.11

692.22

ng/l

0.23

298

Gout, strict definition

486

0.60

2.11

1.0

748.33

681.91

ng/l

0.27

313

Abnormal weight loss

182

1.71

2.11

1.1

1.0

716.00

674.94

ng/l

0.14

111

Superficial injury of abdomen, lower back and pelvis

283

1.56

2.10

1.0

759.26

726.27

ng/l

0.15

186

Non-ischemic cardiomyopathy

726

0.70

2.10

1.0

651.93

708.54

ng/l

0.59

468

Abnormal findings on diagnostic imaging of lung

110

1396

0.77

2.09

1.0

772.36

701.27

ng/l

0.92

905

Heart failure and bmi 25plus

627

0.70

2.09

1.0

794.00

755.78

ng/l

0.27

411

Cough

137

1030

1.28

2.09

1.0

738.75

722.49

ng/l

0.18

104

687

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

700

0.74

2.09

1.0

687.33

727.14

ng/l

0.45

470

Tonsillectomy and adenotomy

674

0.71

2.08

1.0

842.00

779.81

ng/l

0.44

489

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

320

1852

1.17

2.06

1.0

729.48

749.86

ng/l

0.34

234

1265

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

161

1368

0.80

2.03

1.1

1.0

673.09

727.88

ng/l

0.85

107

918

Unspecified urinary incontinence

192

1.67

2.03

1.0

766.95

700.86

ng/l

0.32

120

Anorexia (incl.atypical)

2.41

2.02

1.1

1.0

1149.60

680.74

ng/l

—

Ocular pain

133

1.81

1.99

1.1

1.0

777.11

715.70

ng/l

0.27

Atrial fibrillation and flutter with reimbursement

593

0.71

1.99

1.0

718.57

727.81

ng/l

0.07

434

Parodontitis or/and operation codes

206

1005

1.22

1.97

1.0

759.35

764.14

ng/l

0.05

144

702

Cardiomyopathy (excluding other)

388

0.57

1.96

1.0

748.31

714.99

ng/l

0.14

257

Other heart diseases

144

752

1.27

1.96

1.0

777.50

751.43

ng/l

0.26

100

558

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

643

0.67

1.95

1.0

741.88

716.08

ng/l

0.13

429

Temporomandibular joint disorders

297

1.52

1.94

1.0

818.41

712.26

ng/l

0.80

221

Hypertrophic disorders of skin

2.12

1.92

1.0

843.63

720.00

ng/l

—

Acute alcohol intoxication, ICD10

446

1.42

1.92

1.0

810.48

746.22

ng/l

0.60

304

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

145

1240

0.80

1.90

1.1

1.0

699.19

719.87

ng/l

0.22

816

Melanocytic naevi

700

0.68

1.89

1.0

733.47

727.05

ng/l

0.03

463

Renal tubulo-interstitial diseases

280

1827

1.18

1.89

1.0

722.70

735.12

ng/l

0.19

202

1228

Pedestrian injured in collision with pedal cycle

2.32

1.88

1.0

676.71

567.39

ng/l

—

Non-rheumatic valve diseases

129

1187

0.79

1.87

1.0

747.86

727.39

ng/l

0.17

795

Diabetic retinopathy, excluding more controls

329

1.37

1.87

1.0

838.37

772.28

ng/l

0.51

225

Fibroblastic disorders

593

1.35

1.86

1.0

729.63

694.97

ng/l

0.32

405

Alcohol abuse, main dg

333

1.47

1.85

1.0

826.03

757.95

ng/l

0.53

230

Hypertensive heart and/or renal disease

613

0.71

1.82

1.0

755.59

709.60

ng/l

0.31

391

Cardiomyopathies, Primary/intrinsic

379

0.58

1.82

1.0

748.31

721.12

ng/l

0.11

252

Allergic rhinitis

513

1.37

1.82

1.0

789.16

756.23

ng/l

0.30

353

Colectomy operation

429

0.60

1.82

1.0

809.71

723.76

ng/l

0.41

279

Primary gonarthrosis, bilateral

132

1444

0.80

1.82

1.0

755.76

714.85

ng/l

0.46

973

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

840

0.77

1.82

1.0

745.04

741.89

ng/l

0.02

581

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

840

0.77

1.82

1.0

745.04

741.89

ng/l

0.02

581

Polycystic ovarian syndrome, consortium definition

188

932

1.22

1.81

1.0

820.22

723.16

ng/l

1.89

131

651

Gout, unspecified

562

0.66

1.81

1.0

756.13

709.11

ng/l

0.22

359

Faecal incontinence

191

1.63

1.80

1.0

681.08

672.60

ng/l

0.03

125

Bronchitis, not specified as acute or chronic

191

1.63

1.80

1.1

1.0

647.60

728.97

ng/l

0.68

118

Autoimmune diseases excluding thyroid diseases

335

1606

1.16

1.80

1.0

832.46

725.60

ng/l

3.63

239

1125

Other disorders of the musculoskeletal system and connective tissue

352

1.45

1.80

1.1

1.0

752.94

724.53

ng/l

0.15

236

Other general symptoms and signs

2.19

1.79

1.0

1071.87

596.83

ng/l

—

Carbimazole or st.post thyroidectomy, condition for graves disease

439

0.61

1.79

1.0

754.19

733.45

ng/l

0.08

298

Paracetamol of NSAID medication

157

1.51

1.78

1.0

653.07

711.58

ng/l

0.38

115

Any reimbursement code in KELA

164

665

1.24

1.77

1.0

824.68

745.17

ng/l

1.29

112

477

Psoriatic arthropathies

233

0.47

1.77

1.0

1006.50

708.36

ng/l

—

163

Benign neoplasm: Colon, unspecified

756

0.71

1.77

1.0

806.50

695.69

ng/l

0.98

475

Hypertensive Heart Disease

565

0.69

1.76

1.0

770.88

703.76

ng/l

0.44

357

Viral and other specified intestinal infections

226

1.56

1.76

1.1

1.0

730.56

757.96

ng/l

0.12

145

Other respiratory diseases principally affecting the interstitium

437

0.62

1.76

1.0

817.33

685.51

ng/l

1.04

281

Pain associated with micturition

256

1.53

1.75

1.0

789.31

699.85

ng/l

0.57

165

Abnormal findings on diagnostic imaging of other body structures

298

0.54

1.75

1.0

622.44

689.32

ng/l

—

193

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

349

0.57

1.75

1.1

1.0

557.79

708.68

ng/l

1.25

220

Fall involving bed

2.24

1.74

1.1

1.0

698.00

589.28

ng/l

—

Other specific joint derangements/joint disorders

219

1232

1.19

1.74

1.0

819.85

727.92

ng/l

2.07

157

860

Autoimmune diseases excluding thyroid diseases, strict definition

326

1571

1.16

1.74

1.0

833.02

724.51

ng/l

3.58

231

1100

Maternal care related to the fetus and amniotic cavity and possible delivery problems

511

0.72

1.73

1.0

860.57

761.41

ng/l

0.98

386

Peripheral artery disease

103

1060

0.78

1.73

1.0

739.52

694.67

ng/l

0.47

682

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

385

0.60

1.72

1.0

671.29

728.10

ng/l

0.28

260

Acute tubulo-interstitial nephritis

195

1442

1.20

1.72

1.1

1.0

709.86

717.40

ng/l

0.09

139

939

Vasomotor and allergic rhinitis

100

764

1.29

1.72

1.0

782.68

725.64

ng/l

0.72

532

Use of pramipexole

533

1.35

1.72

1.0

783.33

694.70

ng/l

0.84

353

Aneurysms, operations, SAH

389

1.42

1.72

1.0

601.96

721.73

ng/l

0.97

256

Use of disulfiram, acamprosate or naltrexone

194

1.60

1.71

1.0

825.50

803.51

ng/l

0.10

133

Hepatocellular carcinoma

0.00

1.71

0.0

1.0

—

560.17

—

Nausea and vomiting

541

1.35

1.71

1.0

737.75

710.56

ng/l

0.18

344

Flat foot [pes planus] (acquired)

216

0.46

1.70

1.0

718.20

656.66

ng/l

—

148

Myocardial infarction, strict

125

1139

0.80

1.70

1.0

761.23

715.57

ng/l

0.48

765

Ménière disease

226

1.55

1.70

1.0

706.88

706.83

ng/l

0.00

139

Gout, idiopatic and unspecified

683

0.70

1.69

1.0

756.10

714.37

ng/l

0.23

447

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

146

1167

1.23

1.69

1.0

693.28

747.66

ng/l

0.75

102

812

Malignant neoplasm of small intestine

0.00

1.69

0.0

1.0

—

573.20

—

Other medical care

1026

0.76

1.68

1.0

715.09

696.27

ng/l

0.14

645

Persons encountering health services in other circumstances

105

822

1.28

1.68

1.0

808.47

705.65

ng/l

1.57

544

Early onset COPD

670

0.70

1.67

1.0

839.57

720.26

ng/l

1.12

450

Disorders of sclera, cornea, iris and ciliary body

165

1362

1.21

1.66

1.0

815.05

727.83

ng/l

1.47

119

922

Renal failure

1072

0.77

1.66

1.0

779.11

706.52

ng/l

0.89

688

Fall on and from stairs and steps

571

1.33

1.65

1.0

800.66

726.00

ng/l

0.74

391

Other noninfective gastroenteritis and colitis

485

1.36

1.65

1.0

803.71

717.91

ng/l

0.66

327

Tooth eruption problems

1.93

1.64

1.0

1003.80

760.31

ng/l

—

Struck by thrown, projected or falling objec

1.98

1.64

1.0

563.90

640.88

ng/l

—

Asthma and allergy, excluding more controls

186

1.60

1.64

1.1

1.0

892.43

722.42

ng/l

1.27

126

Valvular heart disease excluding rheumatic fever

132

1190

0.81

1.63

1.0

742.50

728.77

ng/l

0.11

798

Alcohol withdrawal state with delirium

182

1.60

1.0

770.39

714.40

ng/l

0.28

120

Other intracranial haemorrhages

2.08

1.60

1.1

1.0

411.80

634.57

ng/l

—

Hyperlipidaemia, other/unspecified

138

1063

1.23

1.60

1.0

745.08

715.07

ng/l

0.28

680

Asthma (mode)

267

1259

1.17

1.59

1.0

792.08

730.52

ng/l

1.21

179

855

Type 1 diabetes

505

1.35

1.59

1.0

910.02

753.83

ng/l

1.53

342

Disorders of conjunctiva

237

1696

1.17

1.59

1.0

722.25

744.02

ng/l

0.31

167

1166

Cardiac arrhythmias

183

1008

1.20

1.59

1.0

801.70

755.51

ng/l

0.63

129

726

660

0.72

1.59

1.1

1.0

669.64

674.45

ng/l

0.02

406

In situ neoplasms

893

0.75

1.58

1.0

673.14

696.17

ng/l

0.19

581

Allergic conjunctivitis

150

1214

1.22

1.58

1.0

689.89

751.16

ng/l

0.92

105

848

Benign neoplasm of colon, rectum, anus and anal canal

224

1723

1.17

1.58

1.0

746.16

727.02

ng/l

0.23

160

1148

Conjunctivitis

208

1535

1.18

1.57

1.0

719.75

746.57

ng/l

0.37

144

1065

Carcinoma in situ of skin

175

0.46

1.57

1.1

1.0

686.00

622.06

ng/l

—

103

Psoriasis vulgaris

459

0.65

1.56

1.0

918.47

736.28

ng/l

0.84

323

Complications of other internal prosthetic devices, implants and grafts

1.89

1.55

1.0

983.33

639.14

ng/l

—

Diseases of tongue

137

1.69

1.55

1.0

867.23

726.73

ng/l

0.88

Insulin medication

190

1367

1.19

1.55

1.0

778.54

728.51

ng/l

0.77

132

916

Asthma and allergy

189

1.57

1.55

1.1

1.0

892.43

731.64

ng/l

1.17

129

Dental caries 2 and operation codes, only avohilmo

156

1170

0.83

1.55

1.0

769.25

761.48

ng/l

0.08

100

834

Calcific aortic valvular stenosis, diagnosis (helper)

735

0.73

1.54

1.0

664.14

709.31

ng/l

0.38

449

Operations 2 for CAVS

735

0.73

1.54

1.0

664.14

709.31

ng/l

0.38

449

Calcific aortic valvular stenosis

735

0.73

1.54

1.0

664.14

709.31

ng/l

0.38

449

Calcific aortic valvular stenosis, operated

735

0.73

1.54

1.0

664.14

709.31

ng/l

0.38

449

Benign neoplasm of other and unspecified endocrine glands

306

1.44

1.53

1.0

818.79

732.69

ng/l

0.52

202

Crowding of teeth, including avohilmo

0.00

1.53

0.0

1.0

—

703.76

—

Benign neoplasm of brain and other parts of central nervous system

153

1.64

1.53

1.1

1.0

563.13

704.24

ng/l

1.40

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

0.00

1.53

0.0

1.0

—

619.38

—

Autoimmune diseases

358

1608

1.14

1.52

1.0

792.27

725.60

ng/l

1.86

238

1125

Polyuria

571

1.32

1.52

1.0

778.61

721.87

ng/l

0.47

373

Pneumocystosis

0.00

1.52

0.0

1.0

—

600.12

—

Allergic asthma (mode)

442

1.36

1.51

1.0

788.74

702.67

ng/l

0.79

299

Superficial injury of lower leg

485

1.34

1.51

1.0

730.85

726.61

ng/l

0.03

330

Myocardial infarction, with ST-elevation

443

0.65

1.50

1.0

749.41

696.57

ng/l

0.21

285

Actinic keratosis

990

0.78

1.50

1.0

703.42

672.54

ng/l

0.26

619

Arthrosis

260

1232

1.16

1.50

1.0

794.03

727.54

ng/l

1.59

180

857

Anterior Iridocyclitis

460

1.35

1.49

1.0

867.54

728.50

ng/l

1.42

318

Hypertrophic scar

2.01

1.48

1.0

885.86

726.59

ng/l

—

Cerebral aneurysm, nonruptured

202

1.54

1.48

1.0

545.88

751.81

ng/l

1.72

131

Allergic asthma (mode), excluding more controls

444

1.35

1.47

1.0

788.74

705.39

ng/l

0.76

300

Lesion of sciatic nerve

1.82

1.47

1.0

721.63

591.35

ng/l

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

790

0.77

1.47

1.0

731.09

734.07

ng/l

0.02

541

Drug-induced neutropenia

167

0.48

1.46

1.0

751.25

690.52

ng/l

—

105

Other arthrosis

198

1201

1.18

1.46

1.0

780.31

722.48

ng/l

0.99

136

838

Other disorders of bladder

276

1.45

1.46

1.0

672.60

689.79

ng/l

0.11

178

Injuries to the neck

428

1.36

1.45

1.0

725.69

760.19

ng/l

0.24

299

Radiculopathy

377

1.38

1.45

1.1

1.0

771.85

685.44

ng/l

0.51

264

Malignant neoplasm of prostate

104

820

0.80

1.45

1.0

703.78

715.61

ng/l

0.11

541

Malignant melanoma, excluding all cancers (controls excluding all cancers)

498

0.68

1.44

1.0

537.40

718.61

ng/l

1.97

317

Other postsurgical states

140

1.65

1.44

1.0

585.89

687.39

ng/l

—

Psoriatic and enteropathic arthropathies

266

0.56

1.44

1.0

994.50

742.52

ng/l

—

186

Benign neoplasm of meninges

228

1.50

1.43

1.0

782.85

707.50

ng/l

0.31

143

Osteopathies and chondropathies

173

1383

1.19

1.43

1.0

764.23

729.49

ng/l

0.45

111

940

Calcific aortic valvular stenosis, including rheumatic fever

735

0.74

1.42

1.0

678.00

709.31

ng/l

0.24

449

Other strabismus

403

1.36

1.42

1.0

761.68

759.88

ng/l

0.01

278

Assault

188

1.55

1.42

1.0

783.23

802.10

ng/l

0.09

130

Glaucoma

193

1442

1.18

1.41

1.0

731.90

712.91

ng/l

0.20

121

951

L02BG Aromatase inhibitors

807

0.75

1.41

1.0

730.40

724.68

ng/l

0.03

539

Bacterial, viral and other infectious agents

149

1.61

1.40

1.0

753.29

788.19

ng/l

0.16

100

Other enthesopathies

773

1.26

1.40

1.0

870.81

729.27

ng/l

1.71

535

Benign neoplasm: Cerebral meninges

213

1.51

1.40

1.0

805.79

723.13

ng/l

0.34

134

Pneumonitis due to solids and liquids

157

1.60

1.40

1.0

757.24

612.28

ng/l

0.95

Postpartum haemorrhage

263

0.60

1.40

1.0

794.58

809.72

ng/l

0.04

199

Heart failure, not strict

222

1774

0.86

1.40

1.0

754.32

729.37

ng/l

0.34

151

1216

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

844

0.78

1.39

1.1

1.0

696.73

758.24

ng/l

0.59

608

Leisure time condition

355

1.38

1.39

1.0

685.45

734.70

ng/l

0.40

234

Myocardial infarction

140

1208

0.83

1.37

1.0

738.51

719.09

ng/l

0.18

814

Benign neoplasm: Sigmoid colon

502

1.32

1.37

1.0

680.70

706.57

ng/l

0.14

333

Supplementary factors related to causes of morbidity and mortality classified elsewhere

651

1.28

1.37

1.0

776.71

725.70

ng/l

0.44

438

Type of accident

607

1.29

1.37

1.0

751.84

724.32

ng/l

0.19

408

Malignant immunoproliferative diseases

2.64

1.37

1.2

1.0

854.33

582.56

ng/l

—

Antihypertensive medication - note that there are other indications

149

676

1.21

1.37

1.0

800.89

758.67

ng/l

0.49

506

Acute and subacute iridocyclitis

433

1.34

1.37

1.1

1.0

880.60

728.13

ng/l

1.54

304

Chronic periodontitis, complicated

248

0.56

1.35

1.1

1.0

676.64

728.26

ng/l

0.42

167

Keratitis

795

1.25

1.35

1.0

789.06

725.27

ng/l

0.64

541

Endometriosis

448

1.26

1.35

1.0

732.27

721.89

ng/l

0.08

299

Drug-induced osteoporosis with pathological fracture

0.00

1.35

0.0

1.0

—

617.87

—

Vocal cord dysfunction

253

1.43

1.34

1.0

852.72

697.78

ng/l

1.12

175

Congenital malformations of genital organs

1.79

1.34

1.0

987.18

759.03

ng/l

0.97

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

760

1.25

1.34

1.0

767.60

724.56

ng/l

0.44

519

Retinal detachments and breaks

119

976

1.22

1.34

1.0

746.30

717.17

ng/l

0.28

641

Diaphragmatic hernia

120

985

1.22

1.34

1.0

781.44

713.15

ng/l

0.78

661

Laparoscopic left hemicolectomy

0.00

1.34

0.0

1.0

—

579.14

—

Panic disorder

159

1.57

1.34

1.0

930.13

771.26

ng/l

0.71

111

ILD medications: immunosuppressive drugs

148

1688

0.84

1.33

1.0

796.02

728.23

ng/l

0.98

108

1171

Fentanyl

234

0.55

1.33

1.0

798.71

657.22

ng/l

—

143

Other and unspecified follicular disorders

1.98

1.33

1.0

752.14

594.32

ng/l

—

Malignant neoplasm of skin

163

1449

0.85

1.33

1.0

662.81

707.52

ng/l

0.59

952

Benign mammary dysplasia

316

1.40

1.32

1.0

845.45

714.76

ng/l

0.99

214

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

417

0.67

1.32

1.0

537.44

717.36

ng/l

1.41

264

Disorders of skin appendages

125

1032

1.21

1.31

1.0

806.04

748.29

ng/l

0.60

718

malignant neoplasm of male genital organs

106

828

0.81

1.31

1.0

717.01

716.02

ng/l

0.01

547

Oligomenorrhoea

0.00

1.31

0.0

1.0

—

684.24

—

Malignant immunoproliferative diseases

2.53

1.31

1.2

1.0

854.33

548.08

ng/l

—

Ganglion

463

1.32

1.30

1.0

641.41

723.68

ng/l

1.04

328

Chronic diseases of tonsils and adenoids

190

1402

0.86

1.30

1.0

751.13

747.43

ng/l

0.04

141

980

Primary open-angle glaucoma, strict

682

1.26

1.30

1.0

689.27

687.70

ng/l

0.01

436

Excessive vomiting in pregnancy

106

1.70

1.29

1.0

845.23

793.61

ng/l

0.15

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

450

0.69

1.29

1.0

953.59

723.75

ng/l

2.07

282

Disorders of brain, other and unspecified

2.80

1.29

1.0

805.20

540.00

ng/l

—

Inflammatory diseases of prostate (prostatitis)

318

1.39

1.28

1.1

1.0

768.49

779.79

ng/l

0.05

212

Basal cell carcinoma, including avohilmo

147

1373

0.84

1.28

1.0

717.80

700.72

ng/l

0.16

891

Other interstitial pulmonary diseases

378

0.66

1.28

1.0

793.69

685.30

ng/l

0.86

237

Reimbursement for rheumatic diseases

132

1574

0.84

1.28

1.0

835.07

732.19

ng/l

1.40

1080

Benign neoplasm: Colon

183

1537

1.17

1.27

1.0

736.76

715.43

ng/l

0.23

126

1013

Medicines for HER+ breast cancer

936

0.79

1.26

1.1

1.0

736.07

731.44

ng/l

0.03

636

Interstitial lung disease

377

0.66

1.26

1.0

793.69

686.25

ng/l

0.85

236

Interstitial lung disease endpoints

377

0.66

1.26

1.0

793.69

686.25

ng/l

0.85

236

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

328

0.64

1.26

1.0

630.27

692.02

ng/l

0.32

198

Car occupant injured in other and unspecified transport accidents

336

1.37

1.26

1.1

1.0

732.50

755.31

ng/l

0.16

229

Female genital prolapse

444

1.25

1.26

1.0

736.18

720.33

ng/l

0.13

297

Disorders of lacrimal system

130

1084

1.20

1.26

1.0

723.89

721.07

ng/l

0.02

723

Anti-inflammatory and antirheumatic products, non-steroids

314

1.28

1.26

1.0

688.54

704.64

ng/l

0.10

213

Spondylolisthesis/Spondylolysis

414

1.33

1.25

1.0

812.72

691.33

ng/l

1.13

294

Gonarthrosis

244

1222

1.15

1.24

1.0

753.85

724.03

ng/l

0.43

164

849

Superficial injury of thorax

320

1.38

1.24

1.0

851.65

731.44

ng/l

0.94

214

Palmar fascial fibromatosis [Dupuytren]

406

1.33

1.24

1.0

734.05

702.98

ng/l

0.24

272

Papulosquamous disorders

1069

0.80

1.24

1.0

814.88

733.40

ng/l

0.81

737

ILD, hospital admissions

375

0.67

1.24

1.0

793.69

686.25

ng/l

0.85

236

Fracture of shoulder and upper arm

104

850

1.22

1.23

1.0

714.03

712.36

ng/l

0.01

568

Aortic valve malfunction, age under 60 years

240

0.58

1.22

1.0

922.11

762.86

ng/l

—

171

Chronic gastritis

761

1.24

1.22

1.0

819.26

704.44

ng/l

1.51

484

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

2.66

1.22

1.2

1.0

850.20

572.79

ng/l

—

Appendectomy

138

1574

0.84

1.21

1.0

757.58

757.02

ng/l

0.00

106

1078

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

116

1.65

1.21

1.0

764.36

630.18

ng/l

0.83

Abnormal spermatozoa

349

0.66

1.21

1.0

744.72

701.15

ng/l

0.14

226

Melanocytic naevi

640

0.75

1.21

1.0

733.47

724.25

ng/l

0.05

440

Myalgia

469

1.30

1.21

1.0

845.22

721.60

ng/l

1.10

329

Asthma, excluding more controls

259

1213

1.14

1.20

1.0

806.83

730.76

ng/l

1.60

178

824

Other noninflammatory disorders of vagina

132

1.59

1.20

1.0

742.85

690.82

ng/l

0.18

Other specified and unspecified retinal disorders

1.84

1.19

1.0

797.67

622.76

ng/l

—

Basal cell carcinoma

144

1353

0.85

1.19

1.0

718.55

698.10

ng/l

0.19

878

Myocardial infarction, unclassifiable

478

0.73

1.19

1.0

672.24

679.74

ng/l

0.03

295

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

287

0.63

1.19

1.0

754.67

712.33

ng/l

—

176

Degenerative macular diseases

289

1.39

1.19

1.0

654.72

713.80

ng/l

0.46

173

Left ventricular outflow tract obstruction (LVOTO), broad definition

250

0.60

1.18

1.0

922.11

762.33

ng/l

—

177

Insulin, combination of fast acting with intermediate-acting or long-acting

190

1516

1.16

1.18

1.0

778.54

726.89

ng/l

0.81

132

1012

Pulmonary heart disease, diseases of pulmonary circulation

806

0.78

1.18

1.0

738.90

710.31

ng/l

0.20

531

Use of antiglaucoma preparations and miotics

165

1.52

1.17

1.0

523.19

663.70

ng/l

1.34

Myocardial infarction, without ST-elevation

1040

0.82

1.17

1.0

728.02

693.96

ng/l

0.25

678

Postpartum hemorraghe, parous women as controls

251

0.63

1.17

1.0

794.58

793.29

ng/l

0.00

192

Complications of surgical and medical care, not elsewhere classified

311

1992

1.12

1.17

1.0

769.99

740.92

ng/l

0.51

206

1374

Other/unspecified enthesopathies, not elsewhere classified

198

1.47

1.16

1.0

804.44

681.63

ng/l

0.64

132

Neuralgia and neuritis, unspecified

102

1.67

1.16

1.0

634.17

672.02

ng/l

0.24

Cerebral palsy and other paralytic syndromes

223

1.44

1.16

1.0

819.17

721.03

ng/l

0.51

138

Thyrotoxicosis with diffuse goitre

273

0.62

1.16

1.0

589.45

743.44

ng/l

0.85

189

Other malignant neoplasms of skin (=non-melanoma skin cancer)

142

1319

0.85

1.15

1.1

1.0

687.15

702.21

ng/l

0.14

857

Dialysis, with operation codes

333

0.66

1.15

1.0

709.88

720.10

ng/l

0.04

230

Malignant neoplasm of breast, HER-positive

913

0.80

1.15

1.0

729.80

733.03

ng/l

0.02

622

Acute renal failure

520

0.73

1.15

1.0

748.92

708.46

ng/l

0.22

333

Paralytic strabismus

158

1.52

1.14

1.0

766.46

662.14

ng/l

0.35

Ulcerative proctitis

1.69

1.13

1.0

732.60

680.96

ng/l

—

Noninfective enteritis and colitis

127

1068

1.19

1.13

1.0

822.22

734.40

ng/l

1.30

731

Deviated nasal septum

112

932

1.20

1.13

1.1

1.0

773.74

741.97

ng/l

0.31

639

Trochanteric bursitis

292

1.37

1.13

1.0

789.00

670.45

ng/l

1.04

197

Dermatophytosis

331

0.66

1.13

1.0

784.73

724.83

ng/l

0.34

224

Disorders of breast

129

1008

1.19

1.12

1.0

820.86

731.66

ng/l

1.36

697

Dental caries 3 and operation codes, only avohilmo

387

1.23

1.12

1.0

701.98

717.20

ng/l

0.11

260

Functional dyspepsia

626

1.25

1.12

1.0

764.75

714.57

ng/l

0.53

416

First line medication for Crohn's disease

295

1801

0.89

1.12

1.0

796.19

732.55

ng/l

1.64

208

1239

Dental caries 2

164

1494

0.86

1.11

1.0

768.43

754.95

ng/l

0.16

106

1055

Congenital iodine-deficiency syndrome/hypothyroidism

1.97

1.11

1.0

693.20

601.11

ng/l

—

1063

0.82

1.11

1.0

700.65

680.79

ng/l

0.17

665

Inflammatory diseases of female pelvic organs

153

986

1.17

1.10

1.0

775.70

736.35

ng/l

0.48

112

681

DVT of lower extremities

493

0.73

1.10

1.0

727.95

712.03

ng/l

0.11

334

Other retinal disorders

204

1434

1.14

1.09

1.0

752.96

721.42

ng/l

0.38

137

937

Diseases of liver

897

0.80

1.09

1.0

750.55

734.52

ng/l

0.10

611

Disorders of refraction and accommodation

475

1.28

1.09

1.0

745.13

751.25

ng/l

0.04

330

Viral pneumonia

260

1.39

1.09

1.0

809.73

734.72

ng/l

0.42

175

Viral hepatitis

112

1.61

1.08

1.1

1.0

767.55

791.22

ng/l

0.10

Brachial plexus disorders

152

1.52

1.08

1.0

966.17

749.54

ng/l

0.82

105

Glaucoma suspect

116

974

1.19

1.08

1.0

801.63

711.42

ng/l

0.97

640

Other maltreatment syndromes

2.19

1.08

1.0

983.86

676.41

ng/l

—

Enthesopathies of lower limb, excluding foot

496

1.27

1.07

1.0

876.33

709.74

ng/l

2.01

363

Follow-up examination after treatment for malignant neoplasms

169

1.48

1.07

1.1

1.0

661.12

630.53

ng/l

0.15

120

Other diseases of liver

432

0.72

1.07

1.0

894.42

731.17

ng/l

0.83

295

Coxibs

313

1.26

1.06

1.0

803.02

704.64

ng/l

0.87

213

Supervision of normal pregnancy

154

0.63

1.06

1.0

924.33

819.46

ng/l

0.34

125

Subarachnoid haemorrhage

253

1.39

1.06

1.0

623.50

724.68

ng/l

0.57

162

Major coronary heart disease event excluding revascularizations

193

1521

0.87

1.06

1.0

703.98

725.22

ng/l

0.27

121

1020

Sequelae of injuries of upper limb

211

1.42

1.06

1.1

1.0

633.18

735.83

ng/l

0.91

139

Coxarthrosis, primary, with hip surgery

118

1322

0.85

1.05

1.0

740.74

696.00

ng/l

0.57

861

Tongue abnormality

137

1.54

1.05

1.0

858.73

666.76

ng/l

1.21

Heterophoria

121

1.57

1.05

1.0

1076.00

734.87

ng/l

—

Acute pharyngitis

218

1.41

1.05

1.0

626.00

776.61

ng/l

2.16

148

Ulcer of oesophagus

170

1.47

1.04

1.0

735.54

683.76

ng/l

0.26

Benign neoplasm: Colon, unspecified

691

0.78

1.04

1.0

806.50

712.02

ng/l

0.78

450

Retinal detachment with retinal break

340

1.33

1.04

1.1

1.0

808.76

718.37

ng/l

0.58

222

Acetic acid derivatives and related substances

312

1.25

1.04

1.0

786.09

700.48

ng/l

0.92

212

DVT of lower extremities and pulmonary embolism

1106

0.83

1.04

1.0

737.18

717.68

ng/l

0.18

730

Abnormal findings on examination of blood, without diagnosis

149

1200

1.16

1.04

1.0

762.76

725.26

ng/l

0.52

100

798

Dental caries 2, only avohilmo

160

1455

0.87

1.03

1.0

770.78

752.31

ng/l

0.23

103

1023

Other and unspecified nerve root and plexus disorders, also in other diseases

437

1.28

1.03

1.0

773.53

747.55

ng/l

0.18

295

Hypothermia

2.07

1.03

1.0

817.00

513.00

ng/l

—

Insulin, fast-acting (human)

246

1.38

1.03

1.0

926.83

760.12

ng/l

1.03

165

Other and unspecified tonsillitis

445

1.26

1.03

1.1

1.0

989.49

803.35

ng/l

1.91

317

Ischemic heart diseases

300

1689

1.11

1.02

1.0

737.80

745.47

ng/l

0.11

195

1173

Other follicular disorders

114

1.58

1.02

1.0

750.91

753.01

ng/l

0.01

Other respiratory disorders and diseases

485

0.74

1.01

1.1

1.0

819.00

706.59

ng/l

0.52

312

Other diseases of the respiratory system

485

0.74

1.01

1.1

1.0

819.00

706.59

ng/l

0.52

312

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

168

1784

0.87

1.01

1.0

772.94

723.23

ng/l

0.74

128

1184

Oxicams

312

1.26

1.01

1.0

825.16

700.48

ng/l

1.47

212

Type 1 diabetes, wide definition, subgroup 1

394

1.29

1.01

1.0

901.46

761.90

ng/l

1.40

271

Diabetic neuropathy

221

1.40

0.99

1.1

1.0

831.70

704.93

ng/l

0.72

152

Dental caries 2 and operation codes

161

1469

0.87

0.99

1.0

768.38

752.69

ng/l

0.19

104

1038

Acute nasopharyngitis (common cold)

238

1.38

0.99

1.0

812.17

799.37

ng/l

0.06

170

Collagenous colitis

189

1.43

0.99

1.0

725.15

695.30

ng/l

0.12

122

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

547

1.24

0.99

1.0

730.32

748.87

ng/l

0.13

378

Chronic kidney disease

715

0.79

0.98

1.0

796.36

716.87

ng/l

0.77

457

Dysplasia of cervi uteri

321

0.72

0.98

1.0

699.91

742.92

ng/l

0.20

222

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

390

0.72

0.98

1.0

735.72

720.33

ng/l

0.05

243

Benign neoplasms

304

1530

1.11

0.98

1.0

749.86

748.73

ng/l

0.01

217

1045

Mouth breathing

129

1104

1.17

0.98

1.0

807.25

740.38

ng/l

0.76

764

Drug-induced osteoporosis

0.00

0.98

0.0

1.0

—

639.72

—

Carcinoma in situ of skin of ear and external auricular canal

0.00

0.98

0.0

1.0

—

593.21

—

Portal vein thrombosis

0.00

0.98

0.0

1.0

—

576.40

—

Inflammation of lacrimal passages (acute and unspecified)

0.00

0.98

0.0

1.0

—

615.81

—

Iridocyclitis

512

1.25

0.98

1.0

862.20

733.24

ng/l

1.31

352

Vitamin deficiency

1.67

0.98

1.0

953.56

667.58

ng/l

—

Vitamin deficiency, wide

1.67

0.98

1.0

953.56

667.58

ng/l

—

Deforming dorsopathies

620

1.23

0.97

1.0

748.06

702.36

ng/l

0.39

444

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

0.00

0.97

0.0

1.0

—

603.00

—

Universal erythroderma, KELA reimbursement

0.00

0.97

0.0

1.0

—

589.33

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

165

1410

1.15

0.97

1.0

828.24

744.65

ng/l

1.49

129

973

Ulcer of lower limb, not elsewhere classified

331

0.69

0.97

1.0

964.50

684.49

ng/l

1.13

212

malignant neoplasm of female genital organs

331

0.69

0.97

1.1

1.0

761.07

712.15

ng/l

0.20

219

Asthma

262

1257

1.12

0.97

1.0

800.54

730.23

ng/l

1.44

181

854

Coronary revascularization (ANGIO or CABG)

133

1079

0.86

0.97

1.0

710.11

716.78

ng/l

0.05

724

Disorder of lipoprotein metabolism, unspecified

362

1.30

0.97

1.0

735.47

725.79

ng/l

0.06

228

Meniscus derangement

202

1220

1.13

0.97

1.0

743.01

726.93

ng/l

0.19

148

850

Panniculitis affecting regions of neck and back

1.74

0.96

1.1

1.0

951.33

610.89

ng/l

—

Gonarthrosis, primary, with knee surgery

165

1540

0.87

0.96

1.0

785.28

718.42

ng/l

0.91

1038

Sudden idiopathic hearing loss

247

0.65

0.95

1.1

1.0

549.60

715.45

ng/l

—

160

Budesonide

293

1.33

0.95

1.0

809.50

747.24

ng/l

0.43

204

Diseases of arteries, arterioles and capillaries

180

1526

0.88

0.95

1.0

741.72

712.92

ng/l

0.40

120

1001

Secondary malignant neoplasm of other and unspecified sites

0.00

0.95

0.0

1.0

—

485.89

—

Neuroendocrine tumor and carcinoma of small intestine

0.00

0.95

0.0

1.0

—

600.63

—

Fitting and adjustment of other devices

113

893

1.18

0.95

1.0

731.41

686.28

ng/l

0.50

560

Early onset COPD, excluding more controls

602

0.78

0.94

1.0

839.57

704.64

ng/l

1.34

404

Skin changes due to chronic exposure to nonionizing radiation

1007

0.84

0.94

1.0

697.18

674.95

ng/l

0.19

633

Malignant melanoma

375

0.72

0.94

1.0

500.56

698.61

ng/l

2.97

246

Primary_lymphoid and hematopoietic malignant neoplasms

690

0.80

0.93

1.1

1.0

825.20

711.58

ng/l

0.89

450

Visual impairment including blindness (binocular or monocular)

109

1.56

0.93

1.0

947.42

648.92

ng/l

0.88

Artrosis, including avohilmo

287

1420

1.11

0.93

1.0

771.36

735.01

ng/l

0.74

196

998

Infections of genitourinary tract in pregnancy

150

1.47

0.92

1.0

779.81

720.92

ng/l

0.23

110

Medial epicondylitis

1.72

0.92

1.0

950.29

731.27

ng/l

—

Nephropathy related operations

304

0.69

0.92

1.0

657.29

731.70

ng/l

0.40

207

Irregular menses

106

728

1.18

0.92

1.0

789.08

742.52

ng/l

0.45

523

Pain and other conditions associated with female genital organs and menstrual cycle

283

1.32

0.91

1.1

1.0

737.90

733.99

ng/l

0.02

197

ILD, hospital admissions 1, main diag only

338

0.71

0.91

1.0

793.69

668.91

ng/l

1.04

211

1.66

0.90

1.0

789.14

584.82

ng/l

—

Dental caries 1 and operation codes, only avohilmo

348

1.21

0.90

1.0

686.15

717.42

ng/l

0.22

234

Small fibre neuropathy

1.76

0.90

1.1

1.0

850.00

600.13

ng/l

—

Haemorrhage from respiratory passages

110

870

1.17

0.90

1.0

734.08

702.29

ng/l

0.35

562

Ischaemic heart disease, wide definition

297

1686

1.10

0.89

1.0

739.62

745.04

ng/l

0.07

194

1167

Speech therapy

664

1.21

0.89

1.0

791.21

707.55

ng/l

0.90

443

Divergent concomitant strabismus

135

1.48

0.89

1.1

1.0

747.75

754.05

ng/l

0.02

Other predominantly sexually transmitted diseases, not elsewhere classified

202

1.39

0.89

1.1

1.0

835.30

796.24

ng/l

0.13

146

Benign neoplasm of meninges

254

1.34

0.88

1.0

782.85

711.66

ng/l

0.29

157

Emergency coronary revascularization (for ACS)

150

1231

0.87

0.88

1.0

694.40

712.13

ng/l

0.16

813

Appendicitis, broad definition

180

1855

0.89

0.88

1.1

1.0

834.09

748.78

ng/l

1.42

140

1288

Other and unspecified effects of external causes

502

1.24

0.87

1.0

792.26

748.80

ng/l

0.36

347

Diseases of pulp and periapical tissues, including avohilmo

339

1607

1.10

0.87

1.0

746.70

735.17

ng/l

0.18

234

1081

Gout, FINNGEN

816

0.82

0.87

1.0

729.79

709.07

ng/l

0.14

523

Benign neoplasm: Stomach

237

1.35

0.87

1.1

1.0

752.67

687.95

ng/l

0.34

147

Tinnitus

593

1.22

0.87

1.0

805.49

723.32

ng/l

0.80

412

Dental pulpitis 1

339

1608

1.10

0.87

1.0

747.56

735.26

ng/l

0.20

234

1082

Mycoses

628

0.80

0.87

1.0

765.03

726.17

ng/l

0.29

423

Herpesviral [herpes simplex] infections

229

0.65

0.87

1.0

804.13

710.82

ng/l

—

153

Pulmonary embolism

738

0.81

0.87

1.0

733.39

706.19

ng/l

0.19

491

Dental pulpitis 4

339

1608

1.10

0.86

1.0

747.56

735.26

ng/l

0.20

234

1082

Benign neoplasm of colon, rectum, anus and anal canal

214

1367

1.12

0.86

1.0

751.90

730.82

ng/l

0.25

152

920

Other symptoms and signs involving the circulatory and respiratory systems

136

1.47

0.86

1.0

840.14

692.87

ng/l

0.98

Corneal ulcer

378

1.27

0.86

1.0

727.66

745.11

ng/l

0.10

262

L04AX Other immunosuppressants

128

1472

0.87

0.86

1.0

778.12

736.89

ng/l

0.46

1010

Pulmonary heart disease

737

0.81

0.86

1.1

1.0

733.39

708.07

ng/l

0.18

490

Benign neoplasm: Cerebral meninges

238

1.35

0.86

1.0

805.79

712.76

ng/l

0.40

148

Achilles tendinitis

238

1.35

0.85

1.0

834.00

714.90

ng/l

0.61

178

Benign neoplasm of other and unspecified endocrine glands

343

1.29

0.85

1.0

818.79

720.83

ng/l

0.63

224

Second line medication for Crohn's disease

131

1503

0.87

0.85

1.0

782.21

740.29

ng/l

0.49

1028

Nasal polyp

513

1.23

0.85

1.0

711.48

726.54

ng/l

0.09

346

Soft tissue disorders related to use, overuse and pressure

695

1.20

0.85

1.0

755.73

722.38

ng/l

0.32

477

Dental pulpitis 4, only avohilmo

345

1648

1.09

0.85

1.0

752.13

734.37

ng/l

0.31

236

1111

Polypectomy (DHB20)

170

1.42

0.85

1.0

728.33

695.06

ng/l

0.11

109

Lesion of lateral popliteal nerve

112

1.52

0.85

1.1

1.0

837.58

670.03

ng/l

0.47

Enlarged lymph nodes

317

1.29

0.85

1.0

791.00

714.32

ng/l

0.61

226

Other pleural conditions

239

0.67

0.84

1.0

738.75

656.18

ng/l

—

141

Atypical facial pain

1.57

0.84

1.0

1055.50

688.39

ng/l

—

Other infectious diseases

162

1.42

0.84

1.0

825.00

667.23

ng/l

0.65

100

Nummular dermatitis

196

1.38

0.84

1.0

883.84

695.47

ng/l

1.18

128

Adjustment and management of implanted device

446

0.76

0.84

1.0

669.37

684.71

ng/l

0.09

271

Conduction disorders

756

0.83

1.0

723.51

710.72

ng/l

0.11

487

Acute appendicitis, with complications

501

0.78

0.82

1.1

1.0

704.71

732.22

ng/l

0.16

340

Other menopausal disorders

425

0.81

0.82

1.0

722.27

724.69

ng/l

0.01

291

Urticaria

588

1.21

0.82

1.0

799.10

739.23

ng/l

0.42

412

Hydrocele

266

1.32

0.82

1.0

780.09

759.88

ng/l

0.12

172

Other diseases of blood and blood-forming organs, wide

545

0.79

0.82

1.0

701.40

714.87

ng/l

0.09

370

Malignant neoplasm of breast

119

990

0.87

0.82

1.0

735.20

738.61

ng/l

0.03

682

Pedal cyclist injured in transport accident

453

1.24

0.81

1.0

806.26

742.22

ng/l

0.49

312

Antenatal screening

168

0.70

0.81

1.0

802.80

818.47

ng/l

0.05

135

Non-follicular lymphoma, hilmo, excluding all cancers

272

0.70

0.81

1.0

768.71

693.86

ng/l

0.23

170

Diseases of appendix

183

1866

0.89

0.81

1.1

1.0

832.41

748.61

ng/l

1.41

142

1294

Dental pulpitis 1, only avohilmo

345

1653

1.09

0.81

1.0

751.97

734.35

ng/l

0.30

233

1116

Systemic atrophies primarily affecting the central nervous system

1.58

0.81

1.0

797.88

597.06

ng/l

—

Carpal tunnel syndrome

192

1550

1.12

0.81

1.0

814.21

725.47

ng/l

1.70

143

1059

Primary open-angle glaucoma

825

1.17

0.81

1.0

680.60

686.49

ng/l

0.04

528

Other hammer toe(s) (acquired)

468

0.78

0.80

1.0

881.30

659.56

ng/l

1.67

304

Haemorrhage in early pregnancy

469

1.23

0.80

1.1

1.0

704.76

733.33

ng/l

0.17

339

Familial hypercholesterolemia

427

1.24

0.80

1.0

649.77

714.38

ng/l

0.64

269

Asthma (diagnoses ohter than nonallergic)

250

1941

1.10

0.79

1.0

796.43

734.62

ng/l

1.17

172

1327

Asthma (only as main-diagnosis), excluding more controls

226

1213

1.11

0.79

1.0

805.22

730.76

ng/l

1.45

147

824

Carcinoid syndrome

0.00

0.79

0.0

1.0

—

555.60

—

Asthma, hospital admissions , main diagnosis only

234

1897

1.10

0.79

1.0

807.71

737.17

ng/l

1.42

152

1307

Other and unspecified haemorrhagic conditions

0.00

0.79

0.0

1.0

—

516.38

—

Malignant neoplasm of heart, mediastinum and pleura

0.00

0.79

0.0

1.0

—

527.57

—

Type 1 diabetes, wide definition, subgroup 2

0.00

0.79

0.0

1.0

—

475.69

—

Dissociative [conversion] disorders

1.82

0.79

1.0

976.67

560.00

ng/l

—

L02BA Anti-estrogens

362

0.74

0.78

1.1

1.0

772.78

724.42

ng/l

0.25

241

Varus deformity, not elsewhere classified

0.00

0.78

0.0

1.0

—

488.76

—

Acquired absence of organs, not elsewhere classified

0.00

0.78

0.0

1.0

—

490.40

—

Persons encountering health services for specific procedures, not carried out

131

1.45

0.78

1.0

821.62

657.84

ng/l

0.78

Other abnormal findings of blood chemistry

1.56

0.78

1.0

698.00

662.09

ng/l

—

Injuries to the hip and thigh

132

1059

1.14

0.78

1.0

687.29

718.17

ng/l

0.34

702

Melanoma of uvea

0.00

0.77

0.0

1.0

—

596.30

—

Postprocedural musculoskeletal disorders, not elsewhere classified

165

1.40

0.77

1.1

1.0

777.91

673.40

ng/l

0.62

104

ILD medications

307

1837

0.92

0.77

1.0

823.89

729.22

ng/l

2.98

213

1262

Gonarthrosis [arthrosis of knee](FG)

285

1532

1.10

0.77

1.0

756.51

730.74

ng/l

0.41

197

1058

Nonsuppurative otitis media

263

0.72

0.77

1.0

711.29

748.38

ng/l

0.18

167

Venous thromboembolism

134

1477

0.88

0.77

1.0

764.17

715.78

ng/l

0.67

985

Sub-endpoint used in defining T1D endpoints

574

1.20

0.77

1.0

877.76

738.86

ng/l

1.34

388

Polymyalgia rheumatica

326

0.73

0.76

1.0

628.41

696.51

ng/l

0.33

201

Benign neoplasm: Sigmoid colon

548

1.21

0.76

1.0

680.70

726.69

ng/l

0.27

349

Pulmonary eosinophilia, not elsewhere classified

0.00

0.76

0.0

1.0

—

653.42

—

Other interventions on the root canals of the tooth

0.00

0.76

0.0

1.0

—

623.78

—

Benign neoplasm of breast

268

0.71

0.76

1.0

859.57

710.38

ng/l

0.54

179

Intestinal infectious diseases

268

1906

1.09

0.75

1.0

770.40

746.02

ng/l

0.37

191

1290

Lyme disease

650

1.19

0.75

1.1

1.0

732.02

720.43

ng/l

0.08

441

Abnormalities of heart beat

846

1.16

0.75

1.0

787.56

722.56

ng/l

0.72

554

L02BB Anti-androgens

220

0.68

0.74

1.0

769.86

617.52

ng/l

—

135

Malignant neoplasm of breast, HER2-negative

117

983

0.87

0.74

1.0

739.45

737.92

ng/l

0.01

677

Other and unspecified urticaria

378

1.24

0.74

1.0

815.83

738.35

ng/l

0.45

254

COPD/asthma/ILD related infections

343

1584

1.08

0.74

1.0

779.43

735.85

ng/l

0.93

230

1093

COPD/asthma related infections

343

1584

1.08

0.74

1.0

779.43

735.85

ng/l

0.93

230

1093

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

312

0.74

1.0

660.92

676.41

ng/l

0.07

185

Ulcer of vagina/vulva

1.85

0.73

1.0

625.14

669.92

ng/l

—

UC patients in KELA-register (code 208), prior to 1994

108

1.49

0.73

1.1

1.0

801.89

685.59

ng/l

—

Other disorders of veins

1099

0.86

0.73

1.0

770.06

728.10

ng/l

0.43

772

D07AA Corticosteroids, weak (group I)

231

0.69

0.73

1.2

1.0

870.36

743.33

ng/l

0.51

152

Sulfonylureas

853

0.86

0.73

1.0

723.81

692.47

ng/l

0.27

546

Lateral epicondylitis

307

1.27

0.73

1.0

723.84

729.61

ng/l

0.03

219

Postpartum hemorraghe, all women as controls

253

0.71

0.73

1.0

794.58

807.48

ng/l

0.03

194

Crohn's disease NAS

100

1.50

0.72

1.0

799.33

718.94

ng/l

0.36

Chronic lower respiratory diseases

375

1880

1.08

0.72

1.0

788.69

737.87

ng/l

1.27

260

1289

Endometriosis of rectovaginal septum and vagina

142

1.41

0.72

1.1

1.0

660.82

662.51

ng/l

0.01

Iron deficiency anaemia secondary to blood loss (chronic)

367

0.76

0.71

1.0

597.91

702.35

ng/l

0.98

232

Injuries to the knee and lower leg

362

1920

1.08

0.71

1.0

762.43

741.97

ng/l

0.38

252

1309

Polyarthrosis

556

1.19

0.71

1.0

785.38

686.26

ng/l

1.17

371

Noninfectious colitis NAS

264

1.29

0.71

1.0

850.92

727.86

ng/l

0.71

173

Otalgia

134

1.42

0.71

1.0

575.71

689.72

ng/l

0.78

Other specified and unspecified personality disorders

151

1.39

0.71

1.0

776.00

805.40

ng/l

0.13

Other diseases of upper respiratory tract

358

1729

1.08

0.71

1.0

764.88

736.65

ng/l

0.54

248

1170

Alcoholic gastritis

1.93

0.71

1.2

1.0

907.60

596.38

ng/l

—

Other joint disorders

255

1240

1.10

0.71

1.0

785.26

727.53

ng/l

1.14

175

862

Polyarthropathies

204

1230

1.11

0.70

1.0

798.86

726.89

ng/l

1.27

140

856

Other spirochaetal diseases

655

1.18

0.70

1.1

1.0

732.02

718.35

ng/l

0.10

444

Female infertility, cervigal, vaginal, other or unspecified origin

358

0.80

0.70

1.0

803.39

741.80

ng/l

0.40

252

Asthma (only as main-diagnosis)

229

1257

1.10

0.70

1.0

809.67

730.23

ng/l

1.60

148

854

Maltreatment syndromes

1.71

0.70

1.1

1.0

992.57

792.69

ng/l

—

Conjunctivitis (acute, non atopic)

534

1.20

0.69

1.0

800.80

736.63

ng/l

0.53

364

Insulin, fast-acting

850

1.15

0.69

1.0

817.26

734.33

ng/l

1.01

577

Type 1 diabetes, wide definition

417

1.22

0.69

1.0

901.46

765.72

ng/l

1.35

280

Melanoma in situ of other and unspecified parts of face

1.86

0.68

1.0

563.40

524.27

ng/l

—

Malignant melanoma of skin

285

0.74

0.68

1.0

488.33

699.04

ng/l

2.15

186

Fracture of lower leg, including ankle

164

1468

1.11

0.68

1.0

786.12

736.91

ng/l

0.67

111

1000

Dermatitis due to substances taken internally

102

1.47

0.67

1.1

1.0

729.70

702.03

ng/l

—

Benign neoplasm of major salivary glands

261

0.73

0.67

1.1

1.0

885.42

711.32

ng/l

0.68

164

Ovarian cyst

448

1.16

0.67

1.0

782.73

721.89

ng/l

0.70

299

Alcohol abuse counselling and surveillance

1.79

0.66

1.2

1.0

860.80

606.59

ng/l

—

Insulin, fast-acting or short human

864

1.15

0.66

1.0

819.13

739.62

ng/l

0.96

580

Chronic ulcer of skin, not elsewhere classified

155

0.64

0.65

1.1

1.0

928.00

636.94

ng/l

—

Other and unspecified visual disturbances

197

1.32

0.65

1.0

942.06

713.01

ng/l

1.60

127

Other infective otitis externa

128

1.41

0.65

1.0

776.92

712.77

ng/l

0.22

Other peripheral vascular diseases

171

1.35

0.65

1.0

725.00

678.65

ng/l

0.25

104

Other disorders of bone

412

1.21

0.65

1.0

873.76

748.60

ng/l

1.25

287

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

1.58

0.65

1.1

1.0

720.00

662.07

ng/l

—

Female infertility

367

0.82

0.64

1.0

853.58

740.83

ng/l

0.82

257

L04AA Selective immunosuppressants

493

0.81

0.64

1.0

734.52

756.88

ng/l

0.11

344

Melanoma in situ of other and unspecified parts of face

1.73

0.64

1.0

563.40

510.93

ng/l

—

Seropositive rheumatoid arthritis, strict definition

371

0.78

0.64

1.0

823.05

702.15

ng/l

0.76

242

Cellulitis

496

1.19

0.63

1.0

743.18

728.04

ng/l

0.09

337

Viral warts

177

0.68

0.63

1.0

811.43

736.37

ng/l

—

115

Malignant neoplasm of head and neck

200

0.70

0.63

1.0

636.14

680.16

ng/l

—

129

Coagulation defects, purpura and other haemorrhagic conditions

392

0.79

0.62

1.0

700.00

735.36

ng/l

0.14

262

Inflammatory bowel disease

682

1.16

0.62

1.0

818.80

732.38

ng/l

1.12

477

Benign neoplasm: Rectum

488

1.19

0.62

1.0

741.13

700.42

ng/l

0.32

326

Coronary angioplasty

107

930

0.88

0.62

1.0

695.42

712.41

ng/l

0.12

624

Bell's palsy

270

1.26

0.62

1.0

713.07

731.94

ng/l

0.10

183

Special screening examination for neoplasms

1.59

0.61

1.2

1.0

703.80

622.33

ng/l

—

Corneal degeneration

1.67

0.61

1.0

953.00

663.37

ng/l

—

Corns and callosities

147

1.36

0.61

1.1

1.0

799.55

698.76

ng/l

0.24

Other sexually transmitted chlamydial diseases

1.67

0.61

1.0

1124.00

870.55

ng/l

—

Unspecified haematuria

129

987

1.12

0.61

1.0

751.24

725.10

ng/l

0.27

650

Gastroduodenal ulcer

654

1.16

0.61

1.0

696.48

711.00

ng/l

0.09

424

Benign neoplasm: Adrenal gland

191

1.31

0.61

1.0

793.56

673.02

ng/l

0.47

120

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

0.60

0.0

1.0

—

580.36

—

Cardiomyopathies, Secondary/extrinsic

0.00

0.60

0.0

1.0

—

511.70

—

Carcinoma in situ of breast, lobular

0.00

0.60

0.0

1.0

—

547.47

—

Other congenital malformations of upper alimentary tract

0.00

0.60

0.0

1.0

—

450.91

—

Other and unspecified aplastic anaemias

0.00

0.60

0.0

1.0

—

460.27

—

Tooth agenesis EXCLUDE clefts and syndromes

0.00

0.60

0.0

1.0

—

617.00

—

Ductal carcinoma of pancreas

0.00

0.60

0.0

1.0

—

467.64

—

Bronchitis

280

1979

0.93

0.60

1.0

749.68

742.28

ng/l

0.10

194

1351

Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)

0.00

0.60

0.0

1.0

—

600.67

—

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

0.00

0.60

0.0

1.0

—

576.75

—

COPD differential diagnosis

272

1259

1.08

0.60

1.0

776.11

730.52

ng/l

0.83

199

855

Atopic dermatitis, strict definition

390

1.21

0.60

1.0

883.29

767.03

ng/l

1.01

271

ILD differential diagnosis

272

1259

1.08

0.60

1.0

776.11

730.52

ng/l

0.83

199

855

Other benign neoplasms of skin

1069

0.88

0.60

1.0

654.78

717.05

ng/l

0.76

705

Pollen allergy

198

1.30

0.60

1.0

849.85

819.02

ng/l

0.18

136

Cholelithiasis, broad definition with cholecystitis

245

1818

0.92

0.60

1.0

746.73

736.42

ng/l

0.12

152

1251

Other/unspecified seropositive rheumatoid arthritis

705

0.85

0.60

1.0

841.15

707.37

ng/l

1.20

468

Polyarthritis, unspecified

1.50

0.60

1.0

762.33

634.08

ng/l

—

Benign neoplasm of major salivary glands

255

0.74

0.59

1.1

1.0

885.42

710.51

ng/l

0.69

167

Injury of muscle and tendon at lower leg level

378

0.79

0.59

1.0

690.73

727.35

ng/l

0.20

258

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

0.00

0.59

0.0

1.0

—

514.85

—

Benign neoplasm: Short bones of lower limb

0.00

0.59

0.0

1.0

—

606.56

—

Carcinoma in situ of skin of ear and external auricular canal

0.00

0.59

0.0

1.0

—

554.85

—

Benign neoplasm of middle ear and respiratory system

209

0.72

0.59

1.1

1.0

686.00

709.95

ng/l

—

136

Dentofacial anomalies [including malocclusion]

586

1.17

0.59

1.0

825.26

728.14

ng/l

0.98

413

Hypoparathyroidism

1.53

0.59

1.0

705.80

632.00

ng/l

—

Spirochaetal infections, other/unspecified

192

1.30

0.59

1.1

1.0

777.53

690.73

ng/l

0.31

120

Infections of the skin and subcutaneous tissue

151

1360

1.11

0.58

1.0

749.33

748.83

ng/l

0.00

104

933

ILD, hospital admission 2, with pulmonary infections

220

0.73

0.58

1.0

806.50

693.43

ng/l

—

139

Melanoma of uvea

0.00

0.58

0.0

1.0

—

526.46

—

Combined immunodeficiencies

0.00

0.58

0.0

1.0

—

542.83

—

Seropositive rheumatoid arthritis, wide

714

0.85

0.58

1.0

839.83

705.83

ng/l

1.24

474

Dissocial personality disorder

0.00

0.58

0.0

1.0

—

870.25

—

Accidental poisoning by and exposure to alcohol

0.00

0.58

0.0

1.0

—

475.00

—

Preterm labour and delivery

538

1.17

0.58

1.0

856.08

767.48

ng/l

0.68

389

Adhesive capsulitis of shoulder

428

1.19

0.57

1.0

804.80

698.49

ng/l

0.66

300

Other diseases of oesophagus

211

1.28

0.57

1.0

783.71

690.73

ng/l

0.58

124

Myeloproliferative diseases

207

0.72

0.56

1.0

888.80

689.20

ng/l

—

132

Peripheral artery operations in Hilmo

308

0.78

0.56

1.0

833.25

654.19

ng/l

1.03

185

Non-allergic asthma (mode)

489

1.18

0.56

1.0

783.48

687.96

ng/l

0.87

322

Seropositive rheumatoid arthritis

709

0.86

0.56

1.0

839.83

705.44

ng/l

1.24

462

Dentinal caries

519

1.17

0.56

1.0

713.43

733.01

ng/l

0.14

354

Prepatellar bursitis

107

1.41

0.55

1.0

889.11

653.34

ng/l

—

Overexertion and strenuous or repetitive movements

212

1.28

0.55

1.0

789.50

752.64

ng/l

0.14

138

Fracture of femur

536

1.16

0.55

1.1

1.0

666.41

690.79

ng/l

0.17

336

Non-allergic asthma (mode), excluding more controls

490

1.17

0.55

1.0

783.48

693.72

ng/l

0.80

318

Superficial injury of hip and thigh

302

1.23

0.55

1.0

652.03

711.69

ng/l

0.37

195

Benign neoplasm of breast

251

0.76

0.55

1.0

859.57

730.48

ng/l

0.45

172

Systemic connective tissue disorders

869

0.87

0.54

1.0

733.36

707.38

ng/l

0.18

568

Ankylosing spondylitis

177

1.30

0.54

1.0

893.80

711.74

ng/l

0.68

129

Acne vulgaris

1.58

0.54

1.2

1.0

880.33

845.81

ng/l

—

Malignant neoplasm of breast, HER-negative

514

0.83

0.54

1.0

756.26

703.36

ng/l

0.28

332

Diseases of pulp and periapical tissues

932

0.88

0.54

1.0

724.87

732.29

ng/l

0.06

646

Diseases of middle ear and mastoid

902

0.89

0.53

1.0

792.82

725.12

ng/l

0.73

609

Diseases of the skin and subcutaneous tissue

330

1550

1.07

0.53

1.0

771.55

732.22

ng/l

0.74

218

1067

Entropion and trichiasis of eyelid

193

0.72

0.53

1.1

1.0

730.00

622.19

ng/l

—

109

Burns and corrosions

272

0.77

0.53

1.1

1.0

690.29

754.38

ng/l

0.35

181

Idiopathic gout

238

0.75

0.53

1.0

767.70

643.50

ng/l

—

149

Benign neoplasms

227

1188

1.08

0.52

1.0

761.33

755.71

ng/l

0.06

168

811

Injury of muscle and tendon at wrist and hand level

304

1.22

0.52

1.0

877.43

745.04

ng/l

1.09

211

Other necrotizing vasculopathies (FG)

143

1.33

0.52

1.0

661.38

669.43

ng/l

0.04

Obstructed labour due to maternal pelvic abnormality

350

1.20

0.52

1.0

773.09

763.73

ng/l

0.05

252

Gastric ulcer

433

1.18

0.52

1.0

681.42

697.88

ng/l

0.08

268

Covid-19 suspected case

341

1.20

0.52

1.0

794.72

775.58

ng/l

0.11

235

Varicose veins

184

1510

0.92

0.52

1.0

756.45

725.00

ng/l

0.39

112

1042

Cholelithiasis

236

1780

0.93

0.51

1.0

738.47

730.86

ng/l

0.08

149

1222

Temporomandibular joint disorders, including avohilmo

769

1.13

0.51

1.0

739.53

740.20

ng/l

0.00

547

463

0.84

0.51

1.0

702.84

664.27

ng/l

0.16

276

Misadventures to patients during surgical and medical care

324

1.21

0.50

1.0

716.50

701.99

ng/l

0.08

210

Primary_lymphoid and hematopoietic malignant neoplasms

639

0.86

0.50

1.1

1.0

825.20

722.70

ng/l

0.77

415

Other viral diseases

489

1.16

0.50

1.0

835.72

758.66

ng/l

0.58

342

Non-follicular lymphoma

247

0.77

0.50

1.0

768.71

686.03

ng/l

0.26

158

Other disorders of bone density and structure

1.47

0.50

1.2

1.0

939.17

633.16

ng/l

—

Unspecified misadventure during surgical and medical care

118

1.36

0.50

1.0

798.00

663.15

ng/l

—

Other heart diseases, wide

291

1691

1.07

0.50

1.0

766.69

756.96

ng/l

0.13

203

1185

IBD patients in KELA-register

454

1.17

0.49

1.0

770.71

745.39

ng/l

0.18

321

Allergic contact dermatitis

261

1.23

0.49

1.0

727.25

737.01

ng/l

0.06

176

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

691

0.87

0.49

1.0

841.15

708.21

ng/l

1.19

461

Gout

698

0.87

0.49

1.0

729.79

697.88

ng/l

0.23

465

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

198

1.26

0.49

1.0

925.85

711.01

ng/l

0.63

123

Other disorders of breast

234

1.24

0.49

1.1

1.0

993.86

751.28

ng/l

1.67

163

Heartburn

225

1.25

0.49

1.1

1.0

774.36

723.20

ng/l

0.27

151

Toxic effects of substances chiefly nonmedicinal as to source

216

1.25

0.49

1.0

751.67

749.11

ng/l

0.01

142

All influenza (not pneumonia)

316

1.20

0.49

1.1

1.0

651.16

768.87

ng/l

0.99

213

Varicose veins of other sites

145

1.31

0.48

1.0

585.64

719.45

ng/l

0.77

Pilonidal cyst

110

1.37

0.48

1.0

1139.25

779.19

ng/l

—

Arthropathies

261

1240

1.07

0.48

1.0

785.61

727.53

ng/l

1.23

183

862

Presence of cardiac and vascular implants and grafts

129

1073

0.91

0.48

1.0

700.85

709.04

ng/l

0.07

694

Other pulmonary diagnosis

271

1269

1.07

0.48

1.0

767.45

730.12

ng/l

0.61

196

860

Deep endometriosis

154

1.30

0.48

1.1

1.0

660.82

764.13

ng/l

0.42

Superficial injury of forearm

154

1.30

0.48

1.0

1007.92

722.58

ng/l

0.83

Diabetic retinopathy

505

1.13

0.48

1.0

803.73

754.84

ng/l

0.38

340

Other symptoms and signs involving the urinary system

244

1.23

0.48

1.0

777.50

682.42

ng/l

0.77

158

Other noninflammatory disorders of uterus, except cervix

413

0.86

0.48

1.0

625.26

716.90

ng/l

0.98

273

Dislocation, sprain and strain of joints and ligaments at neck level

244

1.23

0.48

1.0

672.95

769.31

ng/l

0.76

166

Hydronephrosis

256

0.78

0.47

1.0

668.07

668.42

ng/l

0.00

159

Other/unspecified enthesopathies of lower limb, excluding foot

128

1.33

0.47

1.0

946.80

666.06

ng/l

—

Presence of other devices

568

1.14

0.47

1.1

1.0

649.22

702.79

ng/l

0.47

345

Spondylopathies (FG)

281

1.21

0.47

1.0

804.73

740.97

ng/l

0.24

195

Inflammatory disease of cervix uteri

137

1.32

0.47

1.0

907.31

766.91

ng/l

0.51

Pregnancy, childbirth and the puerperium

276

1.16

0.47

1.0

682.06

703.76

ng/l

0.12

169

Injuries to the ankle and foot

149

1477

0.92

0.46

1.0

799.79

753.62

ng/l

0.66

109

1022

Inflammatory bowel disease, strict (require KELA)

457

1.16

0.46

1.0

770.71

755.31

ng/l

0.10

327

Ankylosing spondylitis, ICD10

182

1.27

0.46

1.0

893.80

765.96

ng/l

0.43

122

Gestational diabetes (for exclusion)

251

0.82

0.46

1.0

839.52

795.37

ng/l

0.17

194

Arthropod-borne viral fevers and viral haemorrhagic fevers

232

0.77

0.45

1.1

1.0

672.91

732.61

ng/l

0.25

158

Disorders of calcium metabolism

129

1.32

0.45

1.0

890.45

677.56

ng/l

0.75

Complications of procedures, not elsewhere classified

240

1942

1.07

0.45

1.0

747.92

740.12

ng/l

0.10

167

1335

Lesion of ulnar nerve

338

1.18

0.45

1.0

838.19

742.01

ng/l

0.69

235

Cholecystectomy

188

1788

0.93

0.45

1.0

716.67

736.97

ng/l

0.24

119

1224

Fenamates

227

1.19

0.44

1.0

658.78

723.77

ng/l

0.50

154

Other inflammation of eyelid

283

1.20

0.44

1.0

905.17

694.90

ng/l

1.53

185

Benign neoplasm of middle ear and respiratory system

197

0.76

0.44

1.1

1.0

686.00

699.08

ng/l

—

126

Benign neoplasm: Adrenal gland

202

1.24

0.43

1.0

793.56

708.76

ng/l

0.30

128

Other systemic involvement of connective tissue

640

0.87

0.43

1.0

687.12

697.18

ng/l

0.06

423

Nail disorders

148

1.29

0.43

1.0

719.08

754.18

ng/l

0.14

Disorders of mineral metabolism

184

1.25

0.43

1.0

905.80

721.12

ng/l

0.82

114

Benign neoplasm: Stomach

266

1.20

0.43

1.1

1.0

752.67

712.89

ng/l

0.19

166

Other diseases of intestine

312

1.19

0.43

1.0

658.30

706.45

ng/l

0.36

211

Abnormal serum enzyme levels

875

1.11

0.43

1.1

1.0

787.58

705.36

ng/l

1.10

582

Other systemic involvement of connective tissue (FG)

635

0.88

0.43

1.0

687.12

689.87

ng/l

0.02

411

Wet age-related macular degeneration

354

0.83

0.42

1.1

1.0

631.24

647.79

ng/l

0.07

207

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

659

1.12

0.42

1.0

709.53

743.26

ng/l

0.23

455

Infections with a predominantly sexual mode of transmission

461

1.15

0.42

1.0

900.52

758.52

ng/l

1.06

322

Other metabolic disorders

239

1.21

0.42

1.0

766.62

746.95

ng/l

0.08

153

Acute appendicitis

174

1765

0.93

0.42

1.1

1.0

832.37

751.41

ng/l

1.30

136

1233

Malignant neoplasm of bladder

162

0.74

0.42

1.0

582.50

628.99

ng/l

—

Diseases of external ear

821

1.11

0.42

1.0

766.14

732.35

ng/l

0.28

555

Peritonsillar abscess

414

0.84

0.42

1.0

957.09

727.94

ng/l

1.24

295

Diseases of arteries, arterioles and capillaries (FINNGEN)

543

0.89

0.42

1.0

725.32

717.14

ng/l

0.06

395

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

203

1.23

0.42

1.0

925.85

718.22

ng/l

0.60

130

Thyroiditis, ILD-related definition

203

1.23

0.42

1.0

891.79

716.54

ng/l

0.77

142

Other necrotizing vasculopathies

158

1.27

0.41

1.0

661.38

681.42

ng/l

0.10

Ulcerative rectosigmoiditis

167

1.26

0.41

1.0

798.38

751.68

ng/l

0.29

111

Diagnoses used for exclusion with ILD

632

1.12

0.41

1.0

758.35

722.62

ng/l

0.29

418

Toxoplasmosis

0.00

0.41

0.0

1.0

—

455.75

—

Osteopathy in diseases classified elsewhere

0.00

0.41

0.0

1.0

—

548.60

—

Anuria and oliguria

0.00

0.41

0.0

1.0

—

562.75

—

Carcinoma in situ of breast, lobular

0.00

0.41

0.0

1.0

—

649.10

—

Disorders of plasma-protein metabolism, not elsewhere classified

0.00

0.41

0.0

1.0

—

526.33

—

Increased muscle tone

0.00

0.41

0.0

1.0

—

535.33

—

Other specified/unspecified nutritional deficiencies

0.00

0.41

0.0

1.0

—

527.80

—

Other injuries of spine and trunk, level unspecified

0.00

0.41

0.0

1.0

—

564.57

—

Melanocytic naevi of lip

0.00

0.41

0.0

1.0

—

532.11

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

0.00

0.41

0.0

1.0

—

554.43

—

Striae atrophicae

0.00

0.41

0.0

1.0

—

566.11

—

Infarction of spleen

0.00

0.41

0.0

1.0

—

507.11

—

ILD medications: nintedanib

0.00

0.41

0.0

1.0

—

436.70

—

Bus occupant injured in other and unspecified transport accidents

0.00

0.41

0.0

1.0

—

623.20

—

Complications peculiar to reattachment and amputation

0.00

0.41

0.0

1.0

—

478.13

—

Lung transplant status

0.00

0.41

0.0

1.0

—

526.89

—

Lung transplantation

0.00

0.41

0.0

1.0

—

526.89

—

Other and unspecified disorders of pigmentation

0.00

0.41

0.0

1.0

—

526.33

—

Other injuries of lower limb, level unspecified

0.00

0.41

0.0

1.0

—

455.75

—

Myelodysplastic syndrome

0.00

0.41

0.0

1.0

—

418.14

—

Unspecified human immunodeficiency virus [HIV] disease

0.00

0.41

0.0

1.0

—

647.22

—

Arthropathy in Crohn disease

0.00

0.41

0.0

1.0

—

492.11

—

Excluding asthma or asthma-COPD overlap

269

1269

1.06

0.41

1.0

773.44

730.12

ng/l

0.76

196

860

Benign lipomatous neoplasm

775

1.11

0.41

1.0

814.71

719.83

ng/l

0.90

529

Polycystic ovarian syndrome

0.00

0.41

0.0

1.0

—

556.09

—

Urticaria and erythema

756

1.11

0.41

1.0

810.80

732.09

ng/l

0.73

526

Dermatitis and eczema

321

1995

1.05

0.41

1.0

781.59

741.54

ng/l

0.85

223

1366

Paget disease

0.00

0.41

0.0

1.0

—

485.78

—

Osteitis due to dental implant

0.00

0.41

0.0

1.0

—

639.36

—

Fibrosis of liver

0.00

0.41

0.0

1.0

—

598.89

—

Leiomyosarcoma

0.00

0.41

0.0

1.0

—

448.10

—

Aspergillosis

0.00

0.41

0.0

1.0

—

549.91

—

Complications following myocardial infarction

0.00

0.41

0.0

1.0

—

440.57

—

Blindness, monocular

0.00

0.41

0.0

1.0

—

480.67

—

Other and unspecified acquired haemolytic anaemias

0.00

0.41

0.0

1.0

—

550.33

—

Aplastic and other anaemias

107

1111

0.91

0.41

1.0

722.71

709.25

ng/l

0.10

709

Other and unspecified acne

0.00

0.40

0.0

1.0

—

522.80

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

0.00

0.40

0.0

1.0

—

668.83

—

Use of glatiramer acetate

0.00

0.40

0.0

1.0

—

593.83

—

Exposure to other specified factors

202

1773

1.07

0.40

1.0

798.47

745.31

ng/l

0.95

148

1217

Gonarthrosis,primary

318

1896

1.05

0.40

1.0

771.59

739.32

ng/l

0.57

213

1311

Demyelinating diseases of the central nervous system

132

1.29

0.40

1.2

1.0

771.36

744.22

ng/l

0.08

Atlantoaxial subluxation

0.00

0.40

0.0

1.0

—

456.67

—

Polyarteritis nodosa

0.00

0.40

0.0

1.0

—

512.10

—

Cervical root disorders

0.00

0.40

0.0

1.0

—

578.90

—

Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)

0.00

0.40

0.0

1.0

—

513.08

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

0.40

0.0

1.0

—

564.54

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

0.40

0.0

1.0

—

552.00

—

Malignant neoplasm of parotid gland

0.00

0.40

0.0

1.0

—

486.91

—

Malignant neoplasm of eye and adnexa

0.00

0.40

0.0

1.0

—

534.56

—

Use of entacapone

0.00

0.40

0.0

1.0

—

485.00

—

Acute mastoiditis

0.00

0.40

0.0

1.0

—

651.88

—

Benign neoplasm: Short bones of lower limb

0.00

0.40

0.0

1.0

—

498.18

—

Migraine without aura, drug-induced

0.00

0.40

0.0

1.0

—

709.08

—

Chronic rhinitis, nasopharyngitis and pharyngitis

767

1.11

0.40

1.0

816.85

714.20

ng/l

1.03

527

Use of cabergoline

0.00

0.40

0.0

1.0

—

505.30

—

Assault by sharp object

0.00

0.40

0.0

1.0

—

610.42

—

Congenital malformations of great arteries

0.00

0.40

0.0

1.0

—

523.67

—

Other bursopathies

325

0.83

0.39

1.0

675.55

701.19

ng/l

0.12

221

Other and unspecified vascular occlusions

214

1.22

0.39

1.0

647.60

670.57

ng/l

0.12

128

Acute drug-induced interstitial lung disorder

0.00

0.39

0.0

1.0

—

466.00

—

Glaucoma secondary to eye inflammation

0.00

0.39

0.0

1.0

—

502.90

—

Bacterial pneumonia (organism specified)

102

1017

0.91

0.39

1.0

743.18

718.75

ng/l

0.22

671

Intracranial and intraspinal abscess and granuloma

0.00

0.39

0.0

1.0

—

580.64

—

Traumatic amputation of wrist and hand

106

1.32

0.39

1.0

1011.78

677.22

ng/l

—

Certolizumab pegol

0.00

0.39

0.0

1.0

—

515.25

—

Anomalies of dental arch relationship, including avohilmo

272

0.82

0.39

1.0

966.60

772.79

ng/l

0.86

192

Stenosis and insufficiency of lacrimal passages

187

1.23

0.39

1.1

1.0

649.42

684.80

ng/l

0.15

118

Other disorders of optic [2nd] nerve and visual pathways

115

1.31

0.38

1.0

857.60

667.99

ng/l

—

Non-allergic asthma

187

1.23

0.38

1.0

801.44

703.56

ng/l

0.45

117

Delivery, wide proxy

337

1.12

0.38

1.0

710.80

722.88

ng/l

0.08

209

Other diseases of anus and rectum

741

1.11

0.37

1.0

757.13

700.28

ng/l

0.53

491

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

674

0.89

0.37

1.1

1.0

828.18

733.99

ng/l

1.06

475

Other (seronegative) rheumatoid arthritis, wide

462

0.87

0.37

1.0

728.16

714.48

ng/l

0.08

308

Chalazion

243

1.19

0.37

1.1

1.0

757.81

737.47

ng/l

0.08

163

Complications of medical and surgical care

214

1913

1.06

0.37

1.0

792.33

733.67

ng/l

1.09

151

1298

Problems related to lifestyle

188

1.22

0.37

1.0

740.53

717.45

ng/l

0.09

122

LSIL lesion of the cervix uteri, vagina or vulva

179

1.23

0.37

1.0

579.79

787.65

ng/l

1.78

131

Acute bronchitis

906

0.91

0.37

1.0

675.30

728.13

ng/l

0.59

592

Chronic periapical parodontitis

525

0.88

0.37

1.0

682.41

726.48

ng/l

0.34

360

Asthma, including avohilmo

350

1939

1.05

0.37

1.0

797.26

738.17

ng/l

1.44

234

1336

Lung diseases due to external agents

299

1.17

0.37

1.0

741.19

671.73

ng/l

0.44

191

Delivery

457

1.10

0.36

1.0

719.45

736.30

ng/l

0.12

305

AV-block

457

0.87

0.36

1.0

768.08

685.74

ng/l

0.64

280

Other disorders of prostate

1.36

0.36

1.0

1146.67

661.81

ng/l

—

Superficial injury of wrist and hand

337

1.16

0.36

1.0

791.50

784.04

ng/l

0.03

229

Pregnancy hypertension

719

0.90

0.36

1.1

1.0

708.54

763.94

ng/l

0.48

517

Glucosamine medication

169

1262

1.07

0.36

1.0

734.30

709.10

ng/l

0.28

107

849

Rheumatoid arthritis, including avohilmo

1037

0.92

0.35

1.0

819.32

719.47

ng/l

1.13

688

Biomechanical lesions, not elsewhere classified

1.32

0.35

1.0

759.33

676.68

ng/l

—

Haemorrhoids and perianal venous thrombosis

764

1.10

0.35

1.0

803.86

704.14

ng/l

0.86

499

Azathioprine

310

1.16

0.35

1.0

765.29

745.42

ng/l

0.10

213

Undetermined asthma

309

0.84

0.35

1.0

694.26

693.81

ng/l

0.00

201

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

236

1.19

0.34

1.0

795.52

763.60

ng/l

0.13

161

Obstructed labour due to malposition and malpresentation of fetus

266

1.17

0.34

1.0

663.41

816.68

ng/l

1.57

202

Hypertrophy of breast in women and men

395

1.14

0.34

1.0

793.56

729.40

ng/l

0.38

269

Viral haemorrhagic fevers, not elsewhere classified/unspecified

178

0.79

0.34

1.1

1.0

658.67

741.72

ng/l

—

120

Single spontaneous delivery

457

1.10

0.34

1.0

718.66

736.30

ng/l

0.13

305

Abrasion of teeth

485

1.11

0.34

1.0

765.04

765.07

ng/l

0.00

344

Trigger finger

339

1.15

0.34

1.1

1.0

738.70

706.93

ng/l

0.20

238

Coeliac disease

246

1.18

0.34

1.0

827.91

720.26

ng/l

0.96

164

Separation of retinal layers (serosa)

1.32

0.33

1.1

1.0

702.67

737.38

ng/l

—

Direct fill therapy

286

0.84

0.33

1.0

770.35

735.48

ng/l

0.17

194

Endometriosis ASRM stages 3,4

415

1.13

0.33

1.0

693.77

724.48

ng/l

0.20

285

Noninflammatory disorders of female genital tract

448

0.91

0.33

1.0

784.17

721.89

ng/l

0.63

299

Excessive attrition of teeth

493

1.09

0.33

1.0

778.88

764.61

ng/l

0.12

345

Diseases of the digestive system

121

1121

1.08

0.33

1.0

765.93

708.05

ng/l

0.84

739

Injuries to unspecified part of trunk, limb or body region

188

0.80

0.33

1.0

628.00

690.81

ng/l

—

118

ILD medications: azathioprine

312

1.15

0.33

1.0

765.29

733.75

ng/l

0.17

211

Impacted cerumen

219

1.19

0.33

1.0

778.53

679.68

ng/l

0.50

139

Disturbances of skin sensation

558

1.11

0.33

1.0

832.40

740.33

ng/l

0.77

390

Ectopic pregnancy

371

0.86

0.33

1.1

1.0

783.85

765.58

ng/l

0.07

275

Asthma-related pneumonia

825

1.09

0.32

1.0

835.44

704.75

ng/l

1.36

539

Other condition

275

1.16

0.32

1.0

798.14

730.02

ng/l

0.27

184

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

350

1.14

0.32

1.0

765.33

764.62

ng/l

0.00

250

Disorders of vitreous body and globe

164

1503

1.06

0.32

1.0

709.17

725.75

ng/l

0.20

107

1028

Plantar fascial fibromatosis

210

1.19

0.32

1.0

764.67

706.04

ng/l

0.24

137

Complications predominantly related to the puerperium

435

1.13

0.32

1.0

854.46

741.33

ng/l

1.00

314

Hernia of abdominal wall

115

1238

0.93

0.32

1.0

738.65

732.63

ng/l

0.06

839

Other septicaemia

896

1.08

0.32

1.0

733.46

708.73

ng/l

0.22

580

Injury of eye and orbit

266

1.17

0.32

1.0

800.57

745.57

ng/l

0.26

183

Other and unspecified dermatitis

142

1329

1.07

0.32

1.0

784.85

724.34

ng/l

0.84

902

Benign neoplasm: Parotid gland

198

0.81

0.32

1.1

1.0

834.73

701.66

ng/l

0.48

127

Asthma, hospital admissions 3, pneumonia

826

1.09

0.32

1.0

835.44

703.84

ng/l

1.38

540

Asthma-related pneumonia or sepsis

826

1.09

0.32

1.0

835.44

703.84

ng/l

1.38

540

Ill-defined and unknown causes of mortality

137

1.24

0.32

1.0

549.11

613.83

ng/l

—

Vitamin B12 deficiency anaemia

248

1.17

0.31

1.1

1.0

692.56

662.55

ng/l

0.14

153

Other acute lower respiratory infections

110

1130

0.93

0.31

1.0

694.64

738.35

ng/l

0.53

754

Obesity, other/unspecified

727

0.91

0.31

1.0

877.32

743.30

ng/l

1.67

511

Other female pelvic inflammatory diseases

342

1.14

0.31

1.0

746.39

724.95

ng/l

0.13

231

Benign neoplasm: Colon

179

1294

1.06

0.31

1.0

736.47

727.10

ng/l

0.09

123

864

Benign neoplasm: Tongue

1.35

0.31

1.1

1.0

849.86

635.43

ng/l

—

Short Achilles tendon (acquired)

1.35

0.31

1.3

1.0

481.43

657.42

ng/l

—

Dermatitis

173

1632

1.06

0.31

1.0

786.10

736.14

ng/l

0.75

115

1115

Phlebitis and thrombophlebitis (not including DVT)

559

0.89

0.31

1.0

803.62

714.88

ng/l

0.63

388

Other bacterial intestinal infections

399

1.13

0.31

1.0

743.92

700.15

ng/l

0.30

259

Preparatory care for dialysis

0.73

0.31

1.0

645.00

612.09

ng/l

—

Otitis externa

475

1.12

0.31

1.0

709.80

729.85

ng/l

0.13

327

Erysipelas

167

1436

1.06

0.31

1.0

786.15

729.38

ng/l

0.76

105

960

Undetermined asthma, excluding more controls

304

0.85

0.30

1.0

694.26

691.34

ng/l

0.01

196

Secondary hypertension

173

1.20

0.30

1.1

1.0

750.36

754.06

ng/l

0.01

119

Ulcerative colitis

533

1.11

0.30

1.0

841.86

732.16

ng/l

1.17

366

Convergent concomitant strabismus

1.33

0.30

1.0

800.40

760.73

ng/l

—

Inguinal hernia, bilateral

268

1.16

0.30

1.0

590.53

699.18

ng/l

0.58

176

Benign neoplasm of ovary

400

1.13

0.30

1.0

820.47

709.89

ng/l

0.87

272

Atopic dermatitis, strict definition with reimbursement

434

1.12

0.29

1.0

883.18

745.19

ng/l

1.35

311

Recurring oral aphthae, including avohilmo

282

0.85

0.29

1.0

673.87

716.35

ng/l

0.21

178

Other contact dermatitis

157

1.21

0.29

1.1

1.0

939.64

738.02

ng/l

0.77

103

Rash and other nonspecific skin eruption

206

0.82

0.29

1.1

1.0

745.67

713.30

ng/l

0.08

136

Benign neoplasm of other and ill-defined parts of digestive system

449

1.11

0.29

1.0

812.76

709.24

ng/l

0.95

300

Conductive hearing loss, unspecified

176

1.19

0.28

1.0

844.00

704.53

ng/l

0.50

117

Calculus of kidney and ureter

795

0.92

0.28

1.0

767.52

736.36

ng/l

0.27

539

Other ill-defined and unspecified causes of mortality

121

1.24

0.28

1.0

528.57

608.58

ng/l

—

Chronic laryngitis and laryngotracheitis

364

1.13

0.28

1.0

844.31

708.23

ng/l

1.20

252

ILD medications: prednisolone, methylprednisolone, prednisone

312

1836

0.96

0.28

1.0

819.80

729.22

ng/l

2.93

217

1262

Sarcoidosis

317

1.14

0.28

1.0

769.97

740.65

ng/l

0.15

215

Other arrhythmias

191

1539

0.95

0.28

1.0

768.00

743.45

ng/l

0.30

125

1069

Paralytic ileus and intestinal obstruction

651

1.09

0.28

1.0

785.63

705.60

ng/l

0.68

428

Other specified/unspecified hearing loss

186

1.18

0.28

1.1

1.0

709.31

678.84

ng/l

0.09

115

Dipeptidyl peptidase 4 (DPP-4) inhibitors

327

1.13

0.27

1.1

1.0

662.62

707.43

ng/l

0.36

214

Other and unspecified iron deficiency

741

0.92

0.27

1.0

721.28

712.03

ng/l

0.06

482

Codeine

291

1534

1.04

0.27

1.0

822.41

711.77

ng/l

4.12

197

1046

Lichen planus, including avohilmo

451

1.11

0.27

1.0

841.32

722.58

ng/l

0.92

306

Other otitis externa (chronic)

131

1.22

0.27

1.0

849.25

694.05

ng/l

—

Pedal cyclist injured in noncollision transport accidents

224

1.16

0.27

1.0

664.95

739.58

ng/l

0.46

144

Congenital malformations, deformations and chromosomal abnormalities

130

1172

1.06

0.27

1.0

817.29

747.69

ng/l

0.98

818

Endometriosis of pelvic peritoneum

277

1.14

0.26

1.0

700.42

735.94

ng/l

0.17

191

Spondyloarthritis

366

1.12

0.26

1.0

782.77

729.43

ng/l

0.24

253

Combinations of oral blood glucose lowering drugs

856

1.08

0.26

1.1

1.0

721.25

728.59

ng/l

0.07

584

Coxarthrosis

176

1133

1.05

0.26

1.0

772.47

716.02

ng/l

1.00

113

782

Congenital malformations of heart and great arteries

218

0.84

0.26

1.0

818.29

742.21

ng/l

0.26

145

Codeine or tramadol medication

349

1863

1.04

0.26

1.0

826.87

724.80

ng/l

4.04

237

1274

Triptan medication for migraine, min. 3 purchases

106

894

0.94

0.26

1.0

779.57

761.57

ng/l

0.14

655

Visual field defects

182

0.82

0.26

1.1

1.0

805.00

690.01

ng/l

—

114

Rosacea

234

1.15

0.26

1.0

629.42

728.31

ng/l

0.56

157

Hallux valgus (acquired)

109

738

1.07

0.26

1.0

717.10

706.39

ng/l

0.08

503

Asthma, unspecified (mode), excluding more controls

156

1160

1.06

0.26

1.0

807.07

723.48

ng/l

1.17

106

784

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

0.67

0.26

1.0

683.60

712.80

ng/l

—

Benign neoplasm: Rectum, anus and anal canal

549

1.09

0.25

1.0

734.48

699.12

ng/l

0.27

354

Complications of labour and delivery

141

832

0.94

0.25

1.0

747.57

745.40

ng/l

0.02

100

589

Major coronary heart disease event

231

1608

0.96

0.25

1.0

707.62

733.30

ng/l

0.37

144

1087

Benign neoplasm: salivary glands, exclude unknown (D119)

213

0.84

0.25

1.1

1.0

834.73

711.37

ng/l

0.43

137

Inguinal or femoral hernia, bilateral

273

1.14

0.25

1.0

590.53

699.18

ng/l

0.58

176

Disorders of vitreous body

159

1479

1.05

0.24

1.0

703.53

725.03

ng/l

0.27

106

1010

Seronegative rheumatoid arthritis

287

0.87

0.24

1.0

738.12

689.98

ng/l

0.25

192

Atopic dermatitis

119

957

1.06

0.24

1.0

849.39

742.94

ng/l

1.67

675

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

180

0.83

0.24

1.0

819.44

643.70

ng/l

—

107

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

161

1.18

0.24

1.0

807.60

691.01

ng/l

—

103

Crohn disease

255

1.14

0.24

1.0

845.50

743.05

ng/l

0.77

174

Other skin changes

402

0.89

0.24

1.1

1.0

737.21

711.24

ng/l

0.17

261

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

125

748

1.06

0.24

1.0

828.59

749.90

ng/l

0.95

556

Contact with machinery

286

0.87

0.23

1.0

769.67

711.55

ng/l

0.47

201

Endometriosis ASRM stages 1,2

284

1.13

0.23

1.0

700.42

746.93

ng/l

0.24

202

Granulomatous disorders of skin and subcutaneous tissue

1.32

0.23

1.0

1081.80

661.35

ng/l

—

Polyp of the female genital tract

446

0.93

0.23

1.0

780.57

722.09

ng/l

0.54

298

Opioids

303

1535

1.04

0.23

1.0

810.15

712.61

ng/l

3.23

218

1047

Glomerular disorders in diseases classified elsewhere

264

0.87

0.23

1.0

733.47

714.56

ng/l

0.08

179

Other disorders of skin and subcutaneous tissue

200

1756

1.04

0.22

1.0

814.59

720.71

ng/l

1.74

131

1189

Haemangioma and lymphangioma, any site

200

0.85

0.22

1.0

606.55

706.80

ng/l

0.47

126

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

200

0.85

0.22

1.0

850.58

714.01

ng/l

0.40

129

Iron deficiency anaemia

970

0.94

0.22

1.0

691.54

714.76

ng/l

0.20

633

Missing teeth due to accident, extraction or parodontitis

295

0.88

0.22

1.0

945.85

723.85

ng/l

0.96

200

Other/unspecified disorders of vestibular function

1.27

0.22

1.0

608.00

633.85

ng/l

—

Other symptoms and signs involving the digestive system and abdomen

352

1.11

0.22

1.0

796.39

699.84

ng/l

0.69

230

Superficial injury of ankle and foot

189

0.85

0.22

1.1

1.0

814.50

769.54

ng/l

—

123

Obesity due to excess calories

115

1088

1.06

0.22

1.0

874.98

735.70

ng/l

2.35

761

Benign neoplasm: Vulva

1.22

0.22

1.0

795.00

680.07

ng/l

—

Internal derangement of knee

109

1027

1.06

0.22

1.0

765.79

729.55

ng/l

0.39

712

Allergic purpura

1.22

0.22

1.0

1082.40

574.79

ng/l

—

Other anaemias

101

1033

0.94

0.22

1.0

728.16

712.84

ng/l

0.11

664

Asthma/COPD (KELA code 203)

276

1878

1.04

0.21

1.0

780.35

737.87

ng/l

0.81

188

1289

Hypertrophy of breast

324

1.11

0.21

1.0

798.38

739.74

ng/l

0.29

229

Maternal care for known or suspected abnormality of pelvic organs

189

0.88

0.21

1.0

899.29

786.63

ng/l

0.50

142

Striking against or struck by other objects

651

1.07

0.21

1.0

828.13

750.52

ng/l

0.65

447

Other nonautoimmune haemolytic anaemias

0.00

0.21

0.0

1.0

—

392.40

—

Diseases of the respiratory system

215

1034

1.04

0.21

1.0

735.65

735.27

ng/l

0.00

146

706

Urolithiasis

875

0.94

0.21

1.0

763.75

729.65

ng/l

0.31

591

Benign neoplasm: Ciliary body

0.00

0.21

0.0

1.0

—

503.33

—

Benign neoplasm: Ciliary body

0.00

0.21

0.0

1.0

—

503.33

—

Cytomegaloviral hepatitis

0.00

0.21

0.0

1.0

—

482.20

—

Biliary cirrhosis, NAS

0.00

0.21

0.0

1.0

—

568.80

—

Other degenerative disorders of eyelid and periocular area

0.00

0.21

0.0

1.0

—

440.00

—

Fitting and adjustment of external prosthetic device

0.00

0.21

0.0

1.0

—

308.00

—

Benign neoplasm: Skin of other and unspecified parts of face

273

0.88

0.21

1.0

682.31

697.45

ng/l

0.06

168

Malignant neoplasm of thymus

0.00

0.21

0.0

1.0

—

548.20

—

Abnormal findings in peritoneal fluid saliva

0.00

0.21

0.0

1.0

—

545.17

—

Crushing injury of ankle and foot

0.00

0.21

0.0

1.0

—

478.00

—

Malignant neoplasm of hypopharynx

0.00

0.21

0.0

1.0

—

452.50

—

Malignant neoplasm of gum

0.00

0.21

0.0

1.0

—

413.67

—

Systemic disorders of connective tissue in diseases classified elsewhere

0.00

0.21

0.0

1.0

—

483.83

—

Drowning and submersion while in natural water

0.00

0.21

0.0

1.0

—

497.60

—

Neuroendocrine tumor and carcinoma of stomach

0.00

0.21

0.0

1.0

—

463.83

—

Congenital malformations of oesophagus

0.00

0.21

0.0

1.0

—

608.33

—

Systemic sclerosis, icd10

1.19

0.21

1.0

1115.00

660.88

ng/l

—

Severe visual impairment, binocular

0.00

0.21

0.0

1.0

—

476.60

—

Perforation of oesophagus

0.00

0.21

0.0

1.0

—

548.80

—

Acquired clawhand, clubhand, clawfoot and clubfoot

0.00

0.21

0.0

1.0

—

485.33

—

Deaf mutism, not elsewhere classified

0.00

0.21

0.0

1.0

—

522.80

—

Pre-eclampsia

336

0.89

0.21

1.1

1.0

619.35

762.41

ng/l

1.14

245

Juvenile Open Angle Glaucoma

0.00

0.21

0.0

1.0

—

482.20

—

Acute myringitis

0.00

0.21

0.0

1.0

—

516.50

—

Other specified congenital malformation syndromes affecting multiple systems

0.00

0.21

0.0

1.0

—

650.83

—

Procreative management

484

1.08

0.21

1.0

830.83

765.57

ng/l

0.31

346

Dental caries

588

1.08

0.21

1.0

706.43

727.38

ng/l

0.16

399

Other peripheral vertigo

220

0.86

0.21

1.1

1.0

738.54

710.17

ng/l

0.11

138

Benign neoplasm: Rectum

536

1.08

0.21

1.0

741.13

708.30

ng/l

0.25

340

Nezelof syndrome

0.00

0.21

0.0

1.0

—

532.43

—

Other/unspecified mastoiditis and related conditions

0.00

0.21

0.0

1.0

—

506.20

—

Renal agenesis and other reduction defects of kidney

0.00

0.21

0.0

1.0

—

501.33

—

Other dermatomyositis

0.00

0.21

0.0

1.0

—

452.71

—

Benign neoplasm: Retina

0.00

0.21

0.0

1.0

—

526.57

—

Lower leg

0.00

0.21

0.0

1.0

—

372.33

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

0.21

0.0

1.0

—

549.57

—

0.00

0.21

0.0

1.0

—

404.67

—

Mesial bite

0.00

0.21

0.0

1.0

—

463.14

—

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

0.00

0.21

0.0

1.0

—

561.14

—

Excessive, frequent and irregular menstruation

448

1.07

0.21

1.0

836.64

721.89

ng/l

1.16

299

Zoster [herpes zoster]

411

1.10

0.21

1.1

1.0

762.19

703.87

ng/l

0.37

267

Chronic sinusitis

117

1109

1.05

0.21

1.0

739.85

730.15

ng/l

0.08

763

Lichen sclerosus et atrophicus

220

1.14

0.21

1.0

899.40

732.08

ng/l

0.90

145

Benign neoplasm: Ascending colon

344

1.11

0.21

1.0

674.36

689.38

ng/l

0.08

226

Other arthritis (FG)

812

0.94

0.21

1.0

764.27

719.99

ng/l

0.37

543

Calcific tendinitis of shoulder

126

1.19

0.21

1.0

696.50

663.81

ng/l

—

Rheumatoid arthritis

841

0.94

0.21

1.0

805.19

714.35

ng/l

0.97

567

Rheumatoid lung disease

0.00

0.21

0.0

1.0

—

534.63

—

Septicaemia

109

992

1.06

0.21

1.0

713.58

705.29

ng/l

0.07

647

Left side

0.00

0.21

0.0

1.0

—

504.00

—

Malignant neoplasm of bone and articular cartilage of limbs

0.00

0.21

0.0

1.0

—

421.71

—

0.00

0.21

0.0

1.0

—

451.75

—

Carcinoma in situ of endometrium

0.00

0.21

0.0

1.0

—

643.13

—

ILD and respiratory illness in diseases classified elsewhere

0.00

0.21

0.0

1.0

—

451.75

—

Blindness or visual impairment, binocular

0.00

0.21

0.0

1.0

—

452.71

—

Hydrocephalus in other diseases

0.00

0.21

0.0

1.0

—

494.00

—

Benign neoplasm: Retina

0.00

0.21

0.0

1.0

—

466.88

—

Burn and corrosion, body region unspecified

0.00

0.21

0.0

1.0

—

564.57

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.21

0.0

1.0

—

558.83

—

Drug-induced systemic lupus erythematosus

0.00

0.21

0.0

1.0

—

482.86

—

Acute inflammation of orbit

0.00

0.21

0.0

1.0

—

451.67

—

Care involving dialysis

177

0.85

0.21

1.0

708.90

695.82

ng/l

—

112

Dacryoadenitis

0.00

0.21

0.0

1.0

—

480.14

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.21

0.0

1.0

—

520.38

—

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

0.00

0.21

0.0

1.0

—

460.50

—

Ventral hernia

595

0.92

0.21

1.1

1.0

704.93

723.30

ng/l

0.15

397

Asthma, unspecified (mode)

158

1197

1.05

0.20

1.0

803.46

723.41

ng/l

1.11

107

808

Bacterial intestinal infections, IBD co-morbidities

402

1.09

0.20

1.0

737.60

712.88

ng/l

0.14

260

Carcinoma in situ of endometrium

0.00

0.20

0.0

1.0

—

620.25

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

324

0.89

0.20

1.1

1.0

716.22

704.27

ng/l

0.05

212

Typhoid and paratyphoid fevers

0.00

0.20

0.0

1.0

—

489.71

—

Dermatopolymyositis, unspecified

0.00

0.20

0.0

1.0

—

444.56

—

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

0.00

0.20

0.0

1.0

—

515.89

—

Reiter disease

0.00

0.20

0.0

1.0

—

505.71

—

Valgus deformity, not elsewhere classified

0.00

0.20

0.0

1.0

—

554.00

—

Recurrent and persistent haematuria

0.00

0.20

0.0

1.0

—

473.25

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

0.20

0.0

1.0

—

581.11

—

Other congenital malformations of circulatory system

1.25

0.20

1.0

770.67

614.74

ng/l

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

1.25

0.20

1.0

660.00

892.90

ng/l

—

Other disorders of iris and ciliary body

1.23

0.20

1.0

877.00

619.64

ng/l

—

Acne

1.22

0.20

1.2

1.0

880.33

805.24

ng/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

334

0.90

0.20

1.0

848.44

719.81

ng/l

0.87

222

Diabetic retinopathy, strict definition

303

1.10

0.20

1.0

833.28

734.31

ng/l

0.50

209

Foreign body on external eye

344

0.90

0.19

1.0

833.04

748.01

ng/l

0.48

243

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

289

2007

1.03

0.19

1.0

737.39

747.34

ng/l

0.13

215

1362

Persons encountering health services in circumstances related to reproduction

139

986

0.96

0.19

1.0

784.56

774.37

ng/l

0.07

727

Macular hole

146

1.17

0.19

1.0

744.36

698.34

ng/l

0.11

Other embolism and thrombosis

308

1.10

0.19

1.1

1.0

761.86

722.31

ng/l

0.18

204

Other diseases of the digestive system

792

1.06

0.19

1.0

757.84

722.78

ng/l

0.30

518

Perforation of tympanic membrane

203

1.13

0.19

1.0

727.50

683.17

ng/l

0.20

127

Macular pucker

426

0.91

0.18

1.0

740.32

691.67

ng/l

0.39

267

Other and unspecified anaemias

101

1029

0.95

0.18

1.0

728.16

712.19

ng/l

0.12

663

Other/unspecified rheumatoid arthritis

301

0.90

0.18

1.0

680.24

701.60

ng/l

0.10

190

Reactive arthropathies

196

0.87

0.18

1.0

636.25

714.07

ng/l

0.35

136

Oral lichen ruber planus wide, hypothyreosis or thyroxin

128

1.17

0.18

1.1

1.0

842.11

723.57

ng/l

—

Benign neoplasm: Parotid gland

185

0.86

0.18

1.1

1.0

834.73

697.30

ng/l

0.49

118

Lichen ruber planus, wide definition including periferal and oral lichen planus

541

1.07

0.18

1.0

821.10

717.30

ng/l

0.87

373

Coxarthrosis [arthrosis of hip](FG)

193

1346

1.04

0.18

1.0

760.84

719.30

ng/l

0.67

123

918

Benign leiomyoma with endometriosis

367

1.09

0.18

1.0

683.60

710.57

ng/l

0.14

242

Other viral diseases, not elsewhere classified

318

1.10

0.18

1.0

820.60

770.36

ng/l

0.24

216

Certain disorders involving the immune mechanism

454

1.08

0.18

1.0

830.24

731.71

ng/l

0.81

312

Open wound of forearm

153

0.85

0.18

1.0

819.00

738.26

ng/l

—

Benign neoplasm: Transverse colon

271

1.11

0.18

1.0

825.38

667.77

ng/l

0.86

176

Otitis media, unspecified

118

1.17

0.17

1.0

916.80

706.76

ng/l

—

Asthma, hospital admission 2, infections

144

1359

1.04

0.17

1.0

831.28

721.74

ng/l

1.67

908

Asthma-related infections

144

1359

1.04

0.17

1.0

831.28

721.74

ng/l

1.67

908

Open wound of wrist and hand

104

980

1.05

0.17

1.0

707.00

759.03

ng/l

0.78

670

Squamous cell neoplasms and carcinomas of the skin

258

0.89

0.17

1.0

660.92

621.15

ng/l

0.19

150

Lichen planus

329

1.09

0.17

1.1

1.0

889.60

703.56

ng/l

1.40

216

Vasomotor rhinitis (mode)

157

1.15

0.17

1.0

826.09

700.57

ng/l

0.62

102

Other disorders of eyelid

124

1251

0.96

0.17

1.0

697.38

711.71

ng/l

0.13

835

Obesity related asthma

864

1.05

0.17

1.0

872.14

722.08

ng/l

2.01

584

Benign neoplasm: Tongue

1.11

0.17

1.1

1.0

849.86

673.16

ng/l

—

Retinal vascular occlusion

272

1.10

0.17

1.0

677.35

685.72

ng/l

0.04

161

Unspecified acute lower respiratory infection

301

1.10

0.17

1.0

730.57

768.53

ng/l

0.19

202

Benign neoplasm of mouth and pharynx

253

1.11

0.16

1.1

1.0

786.55

700.74

ng/l

0.52

162

GI-bleeding

787

1.05

0.16

1.0

759.46

721.57

ng/l

0.32

512

Neoplasms

204

1130

0.97

0.16

1.0

805.13

754.86

ng/l

0.78

142

768

HSIL lesion of the cervix uteri, vagina or vulva

225

0.89

0.16

1.0

955.71

761.48

ng/l

0.82

165

Bacterial pneumonia, not elsewhere classified

873

0.95

0.16

1.1

1.0

732.05

721.33

ng/l

0.09

590

Other shoulder lesions

187

1.12

0.15

1.0

888.25

693.24

ng/l

1.10

126

Other disorders of adrenal gland

0.78

0.15

1.0

837.83

672.37

ng/l

—

Effects of foreign body entering through natural orifice

545

1.06

0.15

1.0

769.09

754.63

ng/l

0.09

374

Benign neoplasm: Skin of eyelid, including canthus

421

0.93

0.15

1.1

1.0

665.46

707.48

ng/l

0.26

269

Thyrotoxicosis

565

0.94

0.15

1.0

608.76

722.04

ng/l

1.51

382

Leiomyoma of uterus

119

699

0.96

0.15

1.0

783.99

748.99

ng/l

0.40

483

Nonalcoholic fatty liver disease

203

0.89

0.15

1.0

911.55

767.63

ng/l

0.65

133

All dysplastic lesions of the cervix uteri

296

0.91

0.15

1.0

721.47

787.30

ng/l

0.30

218

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

162

1669

0.97

0.15

1.0

808.72

723.13

ng/l

1.49

116

1117

Vestibular neuronitis

226

1.11

0.15

1.0

783.71

723.25

ng/l

0.20

145

Postprocedural endocrine and metabolic disorders, not elsewhere classified

226

1.11

0.15

1.0

737.35

746.18

ng/l

0.03

147

LSIL lesion of the cervix uteri

121

1.16

0.15

1.0

551.11

819.48

ng/l

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

313

1.09

0.15

1.0

752.87

764.32

ng/l

0.05

218

Chronic nephritic syndrome

1.10

0.15

1.2

1.0

471.22

594.21

ng/l

—

Obesity and other hyperalimentation

149

1526

0.97

0.14

1.0

865.31

743.23

ng/l

2.49

106

1063

5-aminosalicylic acid

459

1.07

0.14

1.0

794.71

734.56

ng/l

0.48

318

Disorders of optic nerve and visual pathways

169

1.12

0.14

1.0

864.21

717.03

ng/l

0.49

105

Benign lipomatous neoplasm of other sites/unspecified

223

0.90

0.14

1.0

739.09

691.22

ng/l

0.18

141

Other disorders of patella

368

0.92

0.14

1.0

801.12

722.50

ng/l

0.39

262

Correction of physiology of bite - demanding therapy visit

112

1.16

0.14

1.1

1.0

859.29

727.74

ng/l

—

Other hearing loss

634

0.95

0.14

1.0

689.95

687.42

ng/l

0.01

410

Oral corticosteroids

319

1886

1.02

0.14

1.0

800.85

737.59

ng/l

1.66

220

1297

Coronary atherosclerosis

241

1513

1.03

0.14

1.0

726.92

735.18

ng/l

0.11

157

1038

Cholecystitis

326

0.92

0.14

1.0

819.94

686.65

ng/l

0.48

214

Vitreous haemorrhage

243

0.90

0.13

1.0

701.73

691.86

ng/l

0.03

159

Diabetic nephropathy, excluding more controls

246

1.09

0.13

1.0

781.79

761.48

ng/l

0.09

165

Orchitis and epididymitis

189

1.11

0.13

1.0

922.00

762.25

ng/l

0.67

120

Primary coxarthrosis, bilateral

807

0.95

0.13

1.0

772.82

696.58

ng/l

0.86

523

Pre-eclampsia or poor fetal growth

437

0.94

0.13

1.0

711.47

761.96

ng/l

0.31

315

Carcinoma in situ of breast, intraductal

211

0.90

0.13

1.0

759.86

723.99

ng/l

0.11

141

Haemangioma and lymphangioma, any site

190

0.89

0.13

1.0

606.55

699.51

ng/l

0.42

120

Acute upper respiratory infections of multiple and unspecified sites

180

1387

0.97

0.13

1.0

792.86

746.74

ng/l

0.72

132

952

Pregnancy with abortive outcome

147

794

0.97

0.12

1.0

691.59

729.12

ng/l

0.53

552

Bacterial pneumoniae

101

929

0.96

0.12

1.0

748.34

722.96

ng/l

0.23

625

Disorders of gallbladder, biliary tract and pancreas

297

1955

0.98

0.12

1.0

765.09

741.66

ng/l

0.35

190

1350

Ulcerative colitis, NAS

283

0.92

0.12

1.0

800.85

746.66

ng/l

0.30

198

Salpingitis and oophoritis

427

0.94

0.12

1.1

1.0

788.35

739.19

ng/l

0.21

299

Embedded and impacted teeth

179

0.90

0.12

1.0

906.29

822.20

ng/l

0.30

120

Acute upper respiratory infections

294

1881

0.98

0.12

1.0

817.31

733.27

ng/l

2.34

208

1279

Diabetes mellitus in pregnancy

177

0.92

0.12

1.0

818.53

820.99

ng/l

0.01

140

Chronic pancreatitis

334

0.93

0.12

1.0

870.29

717.00

ng/l

0.88

232

Viral infections characterized by skin and mucous membrane lesions

966

0.96

0.12

1.1

1.0

797.19

726.30

ng/l

0.80

653

Candidiasis

282

0.92

0.12

1.0

786.10

710.44

ng/l

0.39

183

Haemangioma, any site

189

0.90

0.12

1.0

606.55

709.29

ng/l

0.48

119

Exposure to other and unspecified inanimate mechanical forces

116

0.86

0.12

1.1

1.0

689.30

699.60

ng/l

—

Glaucoma-related operations

114

1.14

0.11

1.0

762.75

622.22

ng/l

—

Nutritional anaemias

117

1176

0.97

0.11

1.0

696.84

713.95

ng/l

0.16

764

Other/unspecified synovitis and tenosynovitis

259

1.08

0.11

1.0

737.27

710.66

ng/l

0.14

176

Nontoxic multinodular goitre

507

0.95

0.11

1.0

661.96

696.61

ng/l

0.32

340

Obesity

149

1518

0.97

0.11

1.0

865.31

743.86

ng/l

2.47

106

1058

Glomerular diseases

425

0.94

0.11

1.1

1.0

676.93

716.58

ng/l

0.26

289

Infective dermatitis

271

0.92

0.11

1.0

782.71

710.85

ng/l

0.45

182

Benign neoplasm of ovary

476

0.95

0.11

1.0

820.47

694.51

ng/l

1.06

312

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

178

0.90

0.11

1.0

875.09

720.18

ng/l

0.43

114

Carcinoma in situ of breast, intraductal

209

0.91

0.11

1.0

759.86

726.22

ng/l

0.10

141

Other disorders of the genitourinary system

308

1.07

0.11

1.0

734.43

698.51

ng/l

0.14

200

Hallux rigidus

396

1.06

0.11

1.0

861.68

663.18

ng/l

1.46

264

Tuberculosis, IBD comorbidity

153

1.11

0.11

1.1

1.0

802.90

653.93

ng/l

—

Postmenopausal atrophic vaginitis

434

0.96

0.11

1.0

706.77

718.29

ng/l

0.08

292

Other and unspecified disorders of vitreous body

133

1285

1.03

0.11

1.0

707.22

730.40

ng/l

0.26

879

Other diseases of pancreas

192

1.09

0.10

1.0

748.43

684.82

ng/l

0.30

130

Secondary uncertain malignant neoplasm

301

0.93

0.10

1.0

992.63

683.85

ng/l

2.50

194

Autoimmune diseases related-to ILD

228

2048

0.98

0.10

1.0

798.08

742.92

ng/l

0.96

151

1418

Other disorders of kidney and ureter

309

1.07

0.10

1.0

869.96

707.34

ng/l

1.30

199

Other abnormal uterine and vaginal bleeding

397

0.95

0.10

1.0

798.05

709.34

ng/l

0.70

262

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

173

1.10

0.10

1.0

807.60

693.51

ng/l

—

110

Disorders of muscles

208

0.91

0.10

1.0

804.09

724.10

ng/l

0.40

142

Retinal vascular disorders

280

1.07

0.10

1.0

677.35

684.19

ng/l

0.04

165

Adverse effects, not elsewhere classified

368

1.06

0.10

1.1

1.0

718.00

729.73

ng/l

0.08

250

Other and unspecified rosacea

183

1.09

0.10

1.0

699.14

714.89

ng/l

0.05

118

Coxarthrosis, primary

184

1633

0.98

0.10

1.0

738.21

720.67

ng/l

0.23

112

1092

Retained placenta and membranes, without haemorrhage

228

0.92

0.10

1.1

1.0

900.07

745.40

ng/l

0.75

161

Systemic sclerosis

1.11

0.10

1.0

1115.00

672.50

ng/l

—

Acute appendicitis, no complications

135

1382

0.97

0.09

1.1

1.0

870.06

753.28

ng/l

1.75

105

957

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

301

1926

1.02

0.09

1.0

770.68

742.41

ng/l

0.47

186

1349

Benign neoplasm: Vulva

1.09

0.09

1.0

795.00

676.28

ng/l

—

Systemic sclerosis (FG)

1.09

0.09

1.0

1115.00

601.21

ng/l

—

Benign leiomyoma with endometriosis

422

0.95

0.09

1.0

683.60

697.86

ng/l

0.07

265

Ulcerative colitis (strict definition, all Crohn cases excluded)

281

1.07

0.09

1.0

732.47

760.37

ng/l

0.14

191

Acidosis

1.06

0.09

1.2

1.0

679.40

620.68

ng/l

—

Fracture of foot, except ankle

487

1.05

0.09

1.1

1.0

799.62

746.50

ng/l

0.35

345

Symptoms and signs involving the skin and subcutaneous tissue

180

1830

0.98

0.09

1.0

761.11

734.05

ng/l

0.33

125

1244

Benign neoplasm: Caecum

299

0.94

0.09

1.1

1.0

709.69

701.14

ng/l

0.03

183

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

319

0.94

0.09

1.0

848.44

727.76

ng/l

0.80

211

Unspecified jaundice

1.13

0.09

1.0

872.67

638.27

ng/l

—

Injuries involving multiple body regions

1.11

0.09

1.0

717.17

608.97

ng/l

—

Ulcerative colitis (strict definition, require KELA)

321

1.06

0.09

1.0

752.87

765.47

ng/l

0.06

224

Erosion of teeth, including avohilmo

367

1.05

0.08

1.0

775.38

752.48

ng/l

0.13

266

Endometriosis of ovary

328

0.94

0.08

1.0

693.10

705.96

ng/l

0.06

218

Elevated blood glucose level

165

1.09

0.08

1.0

737.31

692.26

ng/l

0.21

102

Inflammatory bowel disease treatment related agents

337

1886

1.01

0.08

1.0

779.27

737.59

ng/l

1.00

239

1297

Hypokalaemia

253

1.07

0.08

1.0

761.74

739.71

ng/l

0.11

161

Cholesteatoma of middle ear

113

0.88

0.08

1.1

1.0

688.20

624.51

ng/l

—

Atrial fibrillation and flutter

104

660

1.03

0.08

1.0

773.14

734.42

ng/l

0.38

488

Nontoxic goitre/thyroid nodule

775

0.97

0.08

1.0

702.13

697.50

ng/l

0.03

515

Acute suppurative otitis media

273

1.06

0.08

1.1

1.0

950.78

773.22

ng/l

1.02

175

Gestational [pregnancy-induced] hypertension

341

1.05

0.08

1.1

1.0

773.11

772.04

ng/l

0.00

248

Suggestive for eosinophilic asthma

236

0.93

0.08

1.0

757.23

675.57

ng/l

0.23

151

Diseases of peritoneum

236

0.93

0.08

1.0

931.18

708.75

ng/l

1.20

150

Other secondary coxarthrosis

1.05

0.08

1.0

1031.00

644.19

ng/l

—

Degeneration of macula and posterior pole

131

1105

0.98

0.08

1.0

707.23

691.82

ng/l

0.14

694

Dislocation, sprain and strain of joints and ligaments of knee

152

1441

0.98

0.08

1.0

777.86

755.57

ng/l

0.24

109

1014

Dyspnoea

262

1976

1.02

0.07

1.0

792.42

739.16

ng/l

1.12

177

1354

Acute pancreatitis (for exclusion)

510

0.96

0.07

1.0

891.68

726.45

ng/l

1.29

340

Acute pancreatitis

510

0.96

0.07

1.0

891.68

713.87

ng/l

1.44

345

Retinal breaks without detachment

441

1.04

0.07

1.0

698.21

720.69

ng/l

0.13

294

Postmenopausal bleeding

437

1.03

0.07

1.0

724.89

717.06

ng/l

0.05

293

Brain meningioma

108

1.11

0.07

1.0

859.57

698.31

ng/l

—

Other maternal disorders predominantly related to pregnancy

124

797

0.98

0.07

1.0

786.38

753.48

ng/l

0.32

580

Hernia of abdominal wall, postoperative

432

1.04

0.07

1.0

729.39

699.37

ng/l

0.21

328

Tuberculosis, wide

157

1.08

0.07

1.1

1.0

802.90

646.65

ng/l

—

Contraceptive management

692

0.98

0.07

1.0

771.33

792.86

ng/l

0.15

529

Diseases of salivary glands

458

0.96

0.07

1.0

724.27

716.58

ng/l

0.04

313

910

1.02

0.06

1.0

800.52

720.07

ng/l

0.80

611

Vascular disorders of the intestines

138

1.09

0.06

1.0

898.89

635.24

ng/l

—

Cutaneous abscess, furuncle and carbuncle

542

1.03

0.06

1.0

676.19

738.22

ng/l

0.54

372

Ptosis of eyelid

266

1.05

0.06

1.1

1.0

643.18

683.60

ng/l

0.14

171

Other complications of surgical and medical care, not elsewhere classified

207

1.06

0.06

1.0

839.55

690.67

ng/l

0.68

132

Intestinal stricture

790

0.97

0.06

1.0

764.19

721.56

ng/l

0.33

521

Benign lipomatous neoplasm of other sites/unspecified

213

0.94

0.06

1.0

739.09

681.86

ng/l

0.23

135

Superficial injury of shoulder and upper arm

217

1.06

0.06

1.0

644.50

739.88

ng/l

0.60

146

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

153

1554

0.98

0.06

1.0

802.72

723.27

ng/l

1.30

109

1042

Sulfasalazine

771

1.02

0.05

1.0

784.73

724.58

ng/l

0.46

527

Osteonecrosis

129

1.09

0.05

1.0

787.33

695.82

ng/l

—

Menorrhagia

448

1.02

0.05

1.0

828.31

721.89

ng/l

1.28

299

Other benign neoplasms of skin

980

0.98

0.05

1.0

654.78

722.21

ng/l

0.84

655

Inflammatory disease of uterus

202

0.94

0.05

1.0

687.57

769.17

ng/l

0.41

137

Preparation and fitting of bite rail to mouth

273

0.95

0.05

1.0

816.17

776.04

ng/l

0.14

190

Other diseases of stomach and duodenum

149

1.07

0.05

1.0

542.45

697.09

ng/l

1.38

Umbilical hernia

687

0.98

0.05

1.0

798.76

747.58

ng/l

0.53

476

Other blood glucose lowering drugs, excl. Insulins

466

1.03

0.04

1.0

715.23

712.90

ng/l

0.01

302

Pre-eclampsia or eclampsia

373

0.97

0.04

1.1

1.0

655.76

758.29

ng/l

0.72

270

Other diseases of arteries and capillaries

211

0.95

0.04

1.0

758.00

671.75

ng/l

0.33

134

Other specified/unspecified arthritis

685

0.98

0.04

1.0

752.17

716.12

ng/l

0.26

460

Seborrhoeic keratosis

594

0.98

0.04

1.0

843.43

693.77

ng/l

1.56

396

Artificial joint operation, meniscal resection

297

1959

1.01

0.04

1.0

773.60

742.08

ng/l

0.55

205

1343

Spermatocele

180

1.06

0.04

1.0

577.64

729.31

ng/l

1.25

115

Other and unspecified local infections of skin and subcutaneous tissue

200

0.95

0.03

1.0

771.00

714.98

ng/l

0.30

126

Ethmoidectomy

301

0.96

0.03

1.0

773.35

723.82

ng/l

0.22

205

False labour

194

1.04

0.03

1.0

828.75

803.05

ng/l

0.11

154

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

646

1.02

0.03

1.0

793.50

744.67

ng/l

0.40

465

Medical abortion

144

792

0.99

0.03

1.0

732.48

729.12

ng/l

0.03

552

Familial hypercholesterolemia, with ischemic heart disease

250

0.96

0.03

1.0

598.88

662.11

ng/l

0.53

161

Other diseases of blood and blood-forming organs

169

0.95

0.03

1.0

726.40

713.71

ng/l

—

103

Follicular cysts of skin and subcutaneous tissue

421

0.97

0.03

1.0

840.44

746.05

ng/l

0.53

291

Sequelae with surgical and medical care as external cause

489

1.02

0.03

1.0

856.18

715.93

ng/l

0.97

323

Other disorders of teeth and supporting structures

531

0.98

0.03

1.0

834.35

717.65

ng/l

0.83

358

Spontaneous abortion

682

0.99

0.02

1.0

882.38

739.64

ng/l

2.29

495

Thyrotoxicosis, other and/or unspecified

420

0.98

0.02

1.0

605.97

718.69

ng/l

1.22

294

All dysplastic lesions of the cervix uteri, vagina or vulva

387

0.98

0.02

1.0

787.15

775.09

ng/l

0.05

277

Unspecified lump in breast

331

1.03

0.02

1.0

761.48

718.03

ng/l

0.21

226

Benign neoplasm: Skin of eyelid, including canthus

381

1.02

0.02

1.1

1.0

665.46

709.08

ng/l

0.27

249

Bronchiectasis

208

0.96

0.02

1.0

738.86

669.43

ng/l

0.26

125

Unspecified kidney failure

208

0.96

0.02

1.0

758.20

649.99

ng/l

0.80

126

Acute sinusitis

117

1101

0.99

0.02

1.0

840.04

745.81

ng/l

1.41

758

Glaucoma, exfoliation

238

0.97

0.02

1.0

798.18

649.70

ng/l

0.58

143

Benign neoplasm: Caecum

272

1.03

0.02

1.1

1.0

709.69

681.40

ng/l

0.10

171

Melanocytic naevi of other and unspecified parts of face

103

1.07

0.02

1.0

678.40

704.59

ng/l

—

Asthma and opportunity respiratory infection

107

0.93

0.02

1.0

958.20

679.23

ng/l

—

Chondropathies

322

1.02

0.01

1.0

793.75

756.50

ng/l

0.20

225

Foreign body or object entering through skin

117

0.94

0.01

1.1

1.0

809.27

727.21

ng/l

0.54

Leiomyoma of uterus

158

905

0.99

0.01

1.0

747.34

742.78

ng/l

0.05

115

628

338

1792

1.00

0.01

1.0

784.20

730.21

ng/l

1.32

230

1227

Methotrexate

372

1.02

0.01

1.0

768.15

724.26

ng/l

0.21

257

Benign neoplasm: Ascending colon

388

0.98

0.01

1.0

674.36

699.66

ng/l

0.14

242

Haemangioma, any site

177

0.96

0.01

1.0

606.55

709.76

ng/l

0.48

111

Sicca syndrome [Sjögren]

193

1.04

0.01

1.0

819.47

706.25

ng/l

0.40

126

Spontaneous rupture of synovium and tendon

203

1.03

0.01

1.0

598.17

690.91

ng/l

0.64

136

Glomerulonephritis

217

0.97

0.01

1.1

1.0

588.23

731.82

ng/l

1.06

142

Other local infections of skin and subcutaneous tissue

217

0.97

0.01

1.0

771.00

722.59

ng/l

0.25

141

Pedal cyclist injured in other and unspecified transport accidents

223

1.03

0.01

1.0

882.23

765.69

ng/l

0.49

144

Deep bite

137

0.96

0.01

1.0

1145.14

748.73

ng/l

—

Sequelae of external causes of morbidity and mortality

607

0.99

0.01

1.0

815.00

719.65

ng/l

0.71

406

Angina pectoris

207

1392

1.00

0.01

1.0

736.32

728.40

ng/l

0.08

136

942

Blepharochalasis

823

1.01

0.01

1.0

648.28

691.87

ng/l

0.44

538

Unspecified/other endometriosis

1.06

0.01

1.0

725.30

699.23

ng/l

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

114

1.05

0.00

1.2

1.0

754.86

745.10

ng/l

—

Other diseases of hard tissues of teeth

177

1325

1.00

0.00

1.0

784.72

737.21

ng/l

0.78

131

915

Injury of other and unspecified intrathoracic organs

136

0.96

0.00

1.0

764.13

665.94

ng/l

—

Artificial joint re-operation

174

1.03

0.00

1.1

1.0

802.42

679.35

ng/l

0.42

103

Fall on and from ladder

194

1.03

0.00

1.1

1.0

691.09

705.44

ng/l

0.03

128

Benign neoplasm of mouth and pharynx

286

0.98

0.00

1.1

1.0

786.55

718.93

ng/l

0.38

182

Atrophic disorders of skin

306

0.98

0.00

1.0

899.47

713.40

ng/l

1.29

201

Other diseases of lip and oral mucosa

393

0.99

0.00

1.1

1.0

776.97

707.47

ng/l

0.47

266

Pacemaker

828

1.00

0.00

1.0

705.26

696.56

ng/l

0.07

514

Other or unspecified ileus, impaction or obstruction

451

1.00

0.00

1.0

695.84

695.51

ng/l

0.00

297

Melanocytic naevi of other and unspecified parts of face

115

0.96

0.00

1.0

678.40

688.73

ng/l

—

Brain meningioma, excluding all cancers (controls excluding all cancers)

135

0.96

0.00

1.0

799.25

704.67

ng/l

—

Nontoxic single thyroid nodule

165

1.03

0.00

1.0

693.58

729.55

ng/l

0.13

110

Intestinal adhesions without obstruction

195

1.03

0.00

1.0

880.46

681.71

ng/l

1.05

129

Benign neoplasm: Skin of other and unspecified parts of face

245

0.98

0.00

1.0

682.31

708.02

ng/l

0.10

161

FESS (DNB20)

285

1.02

0.00

1.0

773.35

733.31

ng/l

0.17

195

Presbycusis

265

1.01

0.00

1.1

1.0

715.44

613.42

ng/l

0.42

154

TMD related operations

335

1.01

0.00

1.0

826.77

755.70

ng/l

0.31

231

Benign neoplasm of other and ill-defined parts of digestive system

505

0.99

0.00

1.0

812.76

709.06

ng/l

0.96

322

Other nutritional deficiencies

161

1574

1.00

0.00

1.0

881.95

737.93

ng/l

3.67

114

1089

Presence of other functional implants

186

1320

1.00

0.00

1.0

715.48

711.94

ng/l

0.04

132

859

Other diseases of jaws

154

0.97

0.00

1.1

1.0

606.80

782.45

ng/l

—

110

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

226

1.02

0.00

1.0

805.18

660.10

ng/l

0.93

135

Diabetic nephropathy

314

1.01

0.00

1.0

781.79

736.14

ng/l

0.23

204

Paroxysmal tachycardia

489

1.00

0.00

1.1

1.0

772.33

712.40

ng/l

0.43

354

Suppurative and unspecified otitis media

449

1.01

0.00

1.1

1.0

889.58

753.96

ng/l

1.13

303

Other disorders of conjunctiva

347

1.01

0.00

1.0

748.04

702.33

ng/l

0.25

224

Localized swelling, mass and lump of skin and subcutaneous tissue

785

0.99

0.00

1.0

733.42

729.82

ng/l

0.02

528

Triptan medication for migraine, single purchase ok

194

1314

1.00

0.00

1.0

792.50

749.74

ng/l

0.59

135

939

Migraine, single triptan purchase ok & required. ICD-code if available is included

194

1314

1.00

0.00

1.0

792.50

749.74

ng/l

0.59

135

939

Complications of internal orthopaedic prosthetic devices, implants and grafts

602

1.00

0.00

1.0

849.95

679.40

ng/l

1.60

393

Benign neoplasm: Transverse colon

299

1.00

0.00

1.0

825.38

704.36

ng/l

0.60

187

Benign neoplasm: Rectum, anus and anal canal

596

1.01

0.00

1.0

734.48

703.23

ng/l

0.24

376

Benign lipomatous neoplasm

857

1.00

0.00

1.0

814.71

723.41

ng/l

0.86

565

Dermatographic urticaria

107

1.03

0.00

1.0

972.33

722.70

ng/l

—

Thyroiditis

133

0.98

0.00

1.0

1001.88

721.21

ng/l

—

Normotensive glaucoma

207

1.01

0.00

1.0

703.07

680.51

ng/l

0.06

130

Otosclerosis

183

0.98

0.00

1.0

496.50

707.17

ng/l

—

115

Oral leukoplakia and related diseases, including avohilmo

223

0.99

0.00

1.0

813.41

715.07

ng/l

0.41

140

Duodenal ulcer

250

1.00

0.00

1.0

798.16

686.02

ng/l

0.56

149

Use of rasagiline

0.91

0.00

1.2

1.0

886.67

635.54

ng/l

—

Other, unspecified and serous retinal detachments

1.00

0.00

1.1

1.0

796.57

649.81

ng/l

—

Hirsutism, drug-induced

0.00

0.0

1.0

—

466.60

—

Cyst of Bartholin Gland

0.95

0.00

1.3

1.0

648.83

769.26

ng/l

—

Sequelae of injuries of lower limb

190

1.00

0.00

1.1

1.0

866.55

739.26

ng/l

0.58

122

Other and unspecified disease of Bartholin gland

1.02

0.00

1.0

937.67

714.97

ng/l

—

Brain astrocytoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

578.75

—

Secondary and unspecified malignant neoplasm of lymph nodes

210

1.00

0.00

1.0

1032.63

686.96

ng/l

2.53

132

Benign neoplasm: Lacrimal gland and duct

0.00

0.0

1.0

—

549.80

—

Ependymoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

527.00

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS